Method for producing organic material microparticles, and method for modifying organic material microparticles

ABSTRACT

Provided are a method for producing organic material microparticles and a method for modifying organic material microparticles, whereby it becomes possible to improve the crystallinity of organic material microparticles or achieve the crystal transformation of the organic material microparticles while preventing the growth of the organic material microparticles in a solvent. A surfactant is added to a solvent that is capable of partially dissolving organic material microparticles, and then the organic material microparticles are reacted with the solvent. In this manner, it becomes possible to improve the degree of crystallization of the organic material microparticles or achieve the crystal transformation of the organic material microparticles without substantially altering the particle diameters of the organic material microparticles.

This application is a Divisional of application Ser. No. 15/535,980,filed on Jun. 14, 2017, which is the National Phase under 35 U.S.C. §371 of International Application No. PCT/JP2015/085124, filed on Dec.15, 2015, which claims priority under 35 U.S.C. § 119(a) to JapaneseApplication No. 2015-238452 filed on Dec. 7, 2015, Japanese ApplicationNo. 2015-079626 filed on Apr. 8, 2015, Japanese Application No.2015-021639 filed on Feb. 5, 2015, and Japanese Application No.2014-253490 filed on Dec. 15, 2014, all of which are hereby expresslyincorporated by reference into the present application.

TECHNICAL FIELD

The present invention relates to a method for producing an organicmaterial microparticle and a method for modifying an organic materialmicroparticle.

BACKGROUND ART

When conventional organic materials are made to microparticles,especially to nanoparticles, a new function can be expressedsynergistically with the physical properties thereof; and thus, thetechnology to make the organic materials to nanoparticles has been animportant theme in the entire industry.

Because the organic material nanoparticle has an extremely high specificsurface area as compared with those materials in a solid state with thesize of more than several micrometers, they have not only improvedfunctions such as high reactivity and activity but also dramaticallyenhanced characteristics added to their inherent characteristics.Therefore, they are the materials expected to be used in a widetechnical field.

In order to express the characteristics that are expected as the organicmaterial nanoparticle, the particle diameter thereof needs to becontrolled. However, in general, because the solubility of the organicmaterial nanoparticle increases in a solvent, there are problems thatgrowth and coarsening of the particle as well as necking are prone totake place due to recrystallization thereof.

Therefore, as described in Patent Document 1, the production method of abiologically ingestible substance is proposed wherein the substance issubjected to the crushing treatment in a poor solvent containing asurface modifying agent so as to keep the particle size thereof. InPatent Document 9, the production method of an organic pigment isproposed wherein a blue organic pigment such as a copper phthalocyanineis subjected to a dry crushing treatment added with an organic solvent.

However, when mechanical crushing treatments such as those described inthese Patent Documents are carried out, crystallinity of the particle isprone to decrease, so that the problems that the particles after thecrushing treatment aggregate in a solvent thereby causing coarsening ofthe particle can occur. In addition, in many cases, these mechanicalcrushing methods are conducted by means of a medium-using crushingmethod such as those using a ball mill, a sand mill, and a bead mill;and therefore, there have been such problems that contamination withimpurities derived from these equipment cannot be readily avoided andthat enormous time and energy are required to obtain an intendedparticle diameter.

Alternatively, Patent Document 2 discloses the methods in which aco-precipitation method or a crushing treatment method that is addedwith a surface-stabilizing agent in order to produce a nanoparticlecomposition showing stable particle diameter and minimum crystal growthafter a long storage and/or an exposure to a high temperature. However,with regard to the crystallinity thereof, Patent Document 2 describesonly that the particle is present as a crystal phase or an amorphousphase; and thus, there is no description with regard to control of thecrystallinity such as the degree of crystallinity and crystal typethereof. Also the organic material nanoparticle produced by the methodwherein an organic pigment solution in which an organic pigment isdissolved in a good solvent capable of dissolving the said organicpigment is mixed with a poor solvent having a lower solubility to thesame than the good solvent so as to separate the organic pigmentmicroparticle, such as those disclosed in Patent Document 10, oftencontains an amorphous portion; and thus, this method has a problem thatthe particle is prone to undergo coarsening in an organic solvent.

In order to express the characteristics expected as the organic materialnanoparticle, not only control of the particle diameter but also controlof the properties of the particle such as crystallinity and crystal typethereof is important. For example, in polymer compounds such as a resin,it is known that the characteristics of causing secondary aggregate andof sliding property are strongly influenced by the resin's degree ofcrystallinity. Therefore, in Patent Document 3, the method is disclosedwherein crystallinity of the resin microparticle is controlled byheat-treating the resin microparticle in the temperature range betweenequal to or higher than the glass transition temperature thereof andequal to or lower than the melting point thereof so as to obtain theheat-treated resin microparticle. In this method, however, theheat-treatment for a long period of time is necessary, so that themethod with which the crystallinity can be controlled more convenientlyhas been wanted.

Accordingly, in Patent Documents 4 and 8, which are proposed by thepresent applicant, a biologically ingestible microparticle (PatentDocument 4) or an organic pigment microparticle (Patent Document 8) isseparated in a thin film fluid formed between processing surfaces whichare disposed in a position they are faced with each other so as to beable to approach to and separate from each other, at least one of whichrotates relative to the other. With these methods, not only fine anduniform organic material nanoparticle can be readily produced but alsocrystal diameter and crystal type of the separated organic materialnanoparticle can be controlled.

However, the organic material nanoparticle is so fine that the specificsurface area thereof is increased to cause an increase in itssolubility; as a result, owing to the action of an amorphous portion ofthe particles, growth to a coarse particle in a solvent and necking ofthe particle can take place after separation of the particle.

Further, the technology has been known wherein, after the microparticleis separated, the crystallite's diameter of the separated microparticleis changed without changing the particle diameter of the separatedmicroparticle, such as the one disclosed in Patent Document 5. In thistechnology, a uniform and homogeneous particle is obtained by growingthe nucleus or the crystallite of the particle that is separated in athin film fluid formed between at least two processing surfaces whichare disposed in a position they are faced with each other so as to beable to approach to and separate from each other, at least one of whichrotates relative to the other. Specifically, after a fluid having theparticle separated is discharged from between the processing surfaces,the crystallite's diameter of the particle is controlled by controllingthe residence time and the temperature during the said fluid is passingthrough a tubular vessel.

However, in Patent Document 5, although the crystallite's diameter ofthe particle is controlled by the residence time and temperature,problems of coarsening in a solvent and necking of the particle afterthe above-mentioned treatment remain yet to be solved.

In Patent Document 6, in order to prepare the sample for measurement, acopper phthalocyanine powder is introduced into a solution having adispersant dissolved in an organic solvent so as to conduct a dispersiontreatment. However, the copper phthalocyanine microparticle used thereinhas an extremely high crystallinity from the beginning, and the actionof the solvent or the dispersant to the organic material microparticleis completely different from those of the present invention. Moreover,this dispersion treatment is conducted for the purpose of measurement.Therefore, this cannot be regarded as the method for modification of themicroparticle or for control of the properties of the microparticle.

In organic materials, especially in the case of the organic pigment, thecolor characteristics of the organic pigment are dependent on theparticle's properties such as the particle diameter and crystallinity.Therefore, as the use of the organic pigment expands, precise control ofthe properties of the organic pigment and the organic pigmentmicroparticle is wanted. However, there is no decisively effectivemethod to suppress the crystal growth. The often used method in whichthe organic pigment is made to nanoparticle together with a derivativethereof (Patent Document 7) has a problem that development to a requiredcolor is difficult because the color that is characteristic to thederivative can affect the color development of the actually used organicpigment.

As discussed above, organic material microparticles of various materialssuch as a biologically ingestible substance, a resin, and a pigment areused in various fields and applications, wherein in any of theseapplications, properties of the particle such as the particle diameterand the degree of crystallinity can significantly affect the performancethereof. Therefore, not only precise control of the properties of theorganic material microparticle but also a method to suppress the changein the particle properties until actual use of the organic materialmicroparticle is wanted.

CITATION LIST Patent Documents

-   Patent Document 1: Japanese Patent Application Publication No.    H08-501073-   Patent Document 2: Japanese Patent Application Publication No.    2002-538199-   Patent Document 3: Japanese Patent Laid-Open Publication No.    2007-291168-   Patent Document 4: Japanese Patent Application Re-Publication No.    2009-8391-   Patent Document 5: Japanese Patent Laid-Open Publication No.    2014-23997-   Patent Document 6: Japanese Patent Laid-Open Publication No.    2010-242104-   Patent Document 7: International Patent Laid-Open Publication No.    2008/044519-   Patent Document 8: Japanese Patent Laid-Open Publication No.    2009-82902-   Patent Document 9: Japanese Patent Laid-Open Publication No.    2004-244563-   Patent Document 10: Japanese Patent Laid-Open Publication No.    2006-193681

SUMMARY OF THE INVENTION Problem to be Solved by the Invention

As discussed above, in order to utilize the characteristics inherentlyowned by the organic material microparticle, the problem to be solved bythe present invention is to provide a method for producing the organicmaterial microparticle wherein the crystallinity thereof can be enhancedor the crystal transition thereof can be effected with suppressing thegrowth of the organic material microparticle in a solvent. To solve theproblem mentioned above, inventors of the present invention carried outtrial and error, and as a result, they found that when a particleproperty control solution having a surfactant dissolved in a solvent,the surfactant being capable of protecting an organic materialmicroparticle from receiving the action of the said solvent, which has apartial dissolvability to the organic material microparticle at leastpart of which is composed of an amorphous portion, was made to act tothe organic material microparticle, the degree of crystallinity of theorganic material microparticle could be enhanced or the crystaltransition of the organic material microparticle could be effected,without substantially changing the particle diameter of the organicmaterial microparticle. On the basis of this finding, the presentinvention could be achieved.

Means for Solving the Problem

That is to say, the present invention relates to a method for producingan organic material microparticle, wherein a surfactant is added into asolvent which has a partial dissolvability to the organic materialmicroparticle, at least part of which is composed of an amorphousportion, and the said solvent is made to act to the organic materialmicroparticle, thereby enhancing a degree of crystallinity of theorganic material microparticle without substantially changing a particlediameter of the organic material microparticle.

Also, the present invention relates to a method for producing an organicmaterial microparticle, wherein a surfactant is added into a solventwhich has a partial dissolvability to the organic materialmicroparticle, at least part of which is composed of an amorphousportion, and the said solvent is made to act to the organic materialmicroparticle, thereby effecting a crystal transition of the organicmaterial microparticle without substantially changing a particlediameter of the organic material microparticle.

Also, the present invention relates to the method for producing theorganic material microparticle, wherein a rate of change in the particlediameter of the organic material microparticle measured before and afterthe solvent having the surfactant added therein is made to act to theorganic material microparticle (after surfactant treatment (A)/beforesurfactant treatment (B)) is in a range of 1 to 4.

Also, the present invention relates to a method for producing an organicmaterial microparticle, wherein the method comprises: a step 1 in whicha raw material solution of the organic material microparticle is mixedwith a separating solvent L for separating at least one kind of theorganic material microparticles from the raw material solution of theorganic material microparticle thereby effecting separation of theorganic material microparticle (P1); and a step 2 in which a particleproperty control solution having a surfactant, which is capable ofsuppressing growth of the organic material microparticle, added into asolvent which has a partial dissolvability to the organic materialmicroparticle is prepared thereby making the organic materialmicroparticle (P1) act to the said particle property control solution,wherein the step 2 is made to act so as to control particle propertiesof the organic material microparticle (P1).

Also, the present invention relates to the method for producing theorganic material microparticle, wherein the step 2 is made to act so asto change at least any one of degree of crystallinity, crystal type, andcrystal diameter of the organic material microparticle (P1).

Also, the present invention relates to the method for producing theorganic material microparticle, wherein the method comprises a step c inwhich the organic material microparticle (P1) obtained in the step 1 issubjected to washing and/or solvent substitution, and an organicmaterial microparticle (P2) obtained in the step c is made to act to theparticle property control solution.

Also, the present invention relates to the method for producing theorganic material microparticle, wherein the organic materialmicroparticle contains an amorphous portion at least in part thereof.

Also, the present invention relates to the method for producing theorganic material microparticle, wherein at a time when the organicmaterial microparticle is made to act to the solvent or at a time whenthe organic material microparticle is made to act to the particleproperty control solution, a stirring treatment is conducted so as tocontrol properties of the organic material microparticle, or propertiesof the organic material microparticle (P1), or properties of the organicmaterial microparticle (P2), by means of a stirring energy.

Also, the present invention relates to the method for producing theorganic material microparticle, wherein the organic materialmicroparticle is a biologically ingestible substance.

Also, the present invention relates to the method for producing theorganic material microparticle, wherein the organic materialmicroparticle is a resin.

Also, the present invention relates to the method for producing theorganic material microparticle, wherein the organic materialmicroparticle is an organic pigment such as a red organic pigment and ablue organic pigment.

Also, the present invention relates to the method for producing theorganic material microparticle, wherein the step 1 is conducted in amicroreactor in which at least two fluids to be processed, comprisingthe raw material solution of the organic material microparticle and theseparating solvent L, are introduced into between a first processingsurface and a second processing surface which are disposed in a positionthey are faced with each other so as to be able to approach to andseparate from each other, at least one of which rotates relative to theother; a separating force which acts in a direction to separate thefirst processing surface and the second processing surface from eachother is generated by an introduction pressure imparted to between thefirst processing surface and the second processing surface; with keepinga minute distance between the first processing surface and the secondprocessing surface by the separating force, the at least two fluids tobe processed are caused to converge with each other between the firstprocessing surface and the second processing surface that are kept atthe minute distance thereby causing to pass the fluids to be processedthrough between the first processing surface and the second processingsurface so as to form a thin film fluid; and the fluids to be processedare made to react with each other in the thin film fluid. The saidstirring can be conducted by using a stirrer equipped with a rotatingand stirring blade.

In execution of the present invention, the particle diameter of theorganic material microparticle obtained by the production methodmentioned above may be variously changed in accordance with the applieduse and so forth; for example, the particle diameter may be in the rangeof 100 nm or less, or 30 nm or less. For example, the particle diametersof the organic material microparticles measured before and after theorganic material microparticle is made to act to the solvent having apartial dissolvability to the organic material microparticle and havingthe surfactant added therein may be in the range of 100 nm or less, orthe particle diameter of the organic material microparticle (P1) may bein the range of 30 nm or less.

Also, the present invention relates to the method for producing theorganic material microparticle, wherein the solvent does notsubstantially contain a pigment derivative.

Also, the present invention relates to a method for modifying an organicmaterial microparticle, wherein the method is to modify an organicmaterial microparticle without substantially changing a particlediameter of the organic material microparticle; the method comprises astep in which a particle property control solution having a surfactantdissolved in a solvent which has a partial dissolvability to the organicmaterial microparticle is made to act to the organic materialmicroparticle; by conducting this step, a degree of crystallinity of theorganic material microparticle is enhanced so as to modify the organicmaterial microparticle such that the degree of crystallinity thereof maybe matched with a prescribed intended condition.

Also, the present invention relates to the method for modifying theorganic material microparticle, wherein the method is to modify anorganic material microparticle without substantially changing a particlediameter of the organic material microparticle; the method comprises astep in which a particle property control solution having a surfactantdissolved in a solvent which has a partial dissolvability to the organicmaterial microparticle is made to act to the organic materialmicroparticle; and by conducting this step, a crystal type of theorganic material microparticle is changed so as to modify the organicmaterial microparticle in such a way that the crystal type thereof maybe matched with a prescribed intended condition.

Also, the present invention relates to the method for modifying theorganic material microparticle, wherein a rate of change in the particlediameter of the organic material microparticle measured before and afterthe treatment in the step (after the treatment in the step (A)/beforethe treatment in the step (B)) is in a range of 1 to 4.

Also, the present invention relates to the method for modifying theorganic material microparticle, wherein the organic materialmicroparticle before the treatment in the step contains an amorphousportion at least in part thereof.

Advantageous Effects of the Invention

By using the production method of the present invention, not only theparticle growth of the organic material microparticle can be suppressedbut also the crystal type and crystallinity thereof can be controlled;and thus, the organic material microparticle capable of fully expressingthe performance inherently owned by the organic material microparticlecan be produced. In addition, by precisely controlling the properties ofthe organic material microparticle, the method for producing the organicmaterial microparticle capable of satisfying various industrialrequirements can be provided. Further, because properties of theparticle can be conveniently controlled in the organic solvent which hasa partial dissolvability to the organic material microparticle, variouskinds of the organic material microparticle having the characteristicsmatched with respective intended purposes can be produced from one kindof the organic material microparticles, so that the production costthereof can be drastically reduced.

Especially, when the method for producing the organic materialmicroparticle of the present invention is used in a microreactor withthe type of a forced thin film, which is capable of controllingcrystallinity of the particle to be separated, properties of themicroparticle can be further controlled after the organic materialmicroparticle containing an amorphous portion is separated from themicroreactor, so that the organic material microparticle having a verywide range of characteristics can be readily produced.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 This shows one example of the treatment processes according toembodiments of the present invention.

FIG. 2(A) shows a rough cross-sectional view of the microreactor withthe type of a forced thin film according to embodiments of the presentinvention; FIG. 2(B) shows a rough cross-sectional view of themicroreactor with the type of a forced thin film according to otherembodiments of the present invention.

FIG. 3 This shows a rough plan view of the first processing surface ofthe microreactor with the type of a forced thin film shown in FIG. 2(A)and FIG. 2(B).

FIG. 4 This is the TEM picture of the indomethacin microparticlesobtained in the step c in Example A1 of the present invention.

FIG. 5 These are the X-ray diffraction measurement results of theindomethacin microparticles obtained in the step c and the step 2 inExample A1 of the present invention.

FIG. 6 This is the TEM picture of the indomethacin microparticlesobtained in the step 2 in Example A1 of the present invention.

FIG. 7 This is the TEM picture of the indomethacin microparticlesobtained in the step 2 in Example A2 of the present invention.

FIG. 8 This is the TEM picture of the indomethacin microparticlesobtained in the step 2 in Comparative Example A1 of the presentinvention.

FIG. 9 These are the X-ray diffraction measurement results of theindomethacin microparticles obtained in the step c and the step 2 inExample A3 of the present invention.

FIG. 10 This is the TEM picture of the indomethacin microparticlesobtained in the step 2 in Example A3 of the present invention.

FIG. 11 This is the TEM picture of the indomethacin microparticlesobtained in the step 2 in Comparative Example A2 of the presentinvention.

FIG. 12 This is the TEM picture of the indomethacin microparticlesobtained in the step c in Example A4 of the present invention.

FIG. 13 These are the X-ray diffraction measurement results of theindomethacin microparticles obtained in the step c and the step 2 inExample A4 of the present invention.

FIG. 14 This is the TEM picture of the indomethacin microparticlesobtained in the step 2 in Example A4 of the present invention.

FIG. 15 This is the TEM picture of the indomethacin microparticlesobtained in the step 2 in Comparative Example A3 of the presentinvention.

FIG. 16 This is the TEM picture of the curcumin microparticles obtainedin the step c in Example A5 of the present invention.

FIG. 17 These are the X-ray diffraction measurement results of thecurcumin microparticles obtained in the step c and the step 2 in ExampleA5 and Example A6 of the present invention.

FIG. 18 This is the TEM picture of the curcumin microparticles obtainedin the step 2 in Example A5 of the present invention.

FIG. 19 This is the TEM picture of the curcumin microparticles obtainedin the step 2 in Comparative Example A4 of the present invention.

FIG. 20 This is the TEM picture of the curcumin microparticles obtainedin the step 2 in Example A6 of the present invention.

FIG. 21 This is the TEM picture of the curcumin microparticles obtainedin the step 2 in Comparative Example A5 of the present invention.

FIG. 22 This is the SEM picture of the polypropylene microparticlesobtained in the step c in Example A7 of the present invention.

FIG. 23 These are the X-ray diffraction measurement results of thepolypropylene microparticles obtained in the step c and the step 2 inExample A7 of the present invention.

FIG. 24 This is the SEM picture of the polypropylene microparticlesobtained in the step 2 in Example A7 of the present invention.

FIG. 25 This is the SEM picture of the polypropylene microparticlesobtained in the step 2 in Comparative Example A6 of the presentinvention.

FIG. 26 This is the TEM picture of the pirenoxine microparticlesobtained in the step 1 in Example A8 of the present invention.

FIG. 27 This is the TEM picture of the pirenoxine microparticlesobtained in the step 2 in Example A8 of the present invention.

FIG. 28 These are the X-ray diffraction measurement results of thepirenoxine microparticles obtained in the step 1 (before the treatmentin the step 2) and in the step 2 in Example A8 of the present invention.

FIG. 29 This is the picture observed with the transmission electronmicroscope (TEM) of the red pigment nanoparticles of the presentinvention produced in the step 1 of Experiment No. 1-1 of Examples B.

FIG. 30 This is the picture observed with the transmission electronmicroscope (TEM) of the red pigment nanoparticles of the presentinvention produced in the step 2 of Experiment No. 1-2 of Examples B.

FIG. 31 This is the picture observed with the transmission electronmicroscope (TEM) of the red pigment nanoparticles of the presentinvention produced in the step 2 of Experiment No. 1-1 of Examples B.

FIG. 32 This is the picture observed with the transmission electronmicroscope (TEM) of the blue organic pigment microparticles of thepresent invention obtained after the step 1 (washing) of Experiment No.1-7 of Examples C.

FIG. 33 This is the picture observed with the transmission electronmicroscope (TEM) of the blue organic pigment microparticles of thepresent invention obtained after the step 1 (washing) of Experiment No.1-7 of Examples C.

FIG. 34 This is the picture observed with the transmission electronmicroscope (TEM) of the blue organic pigment microparticles of thepresent invention obtained after the step 2 (action) of Experiment No.1-7 of Examples C.

FIG. 35 This is the picture observed with the transmission electronmicroscope (TEM) of the blue organic pigment microparticles of thepresent invention obtained after the step 2 (action) of Experiment No.1-7 of Examples C.

FIG. 36 This is the picture observed with the transmission electronmicroscope (TEM) of the blue organic pigment microparticles produced inExperiment No. 4-4 of Examples C.

FIG. 37 This is the picture observed with the transmission electronmicroscope (TEM) of the blue organic pigment microparticles produced inExperiment No. 3-1 of Examples C.

DESCRIPTION OF THE EMBODIMENTS

Hereinafter, the embodiments of the present invention will be explainedin detail. Meanwhile, the embodiments of the present invention are notlimited only to the embodiments described below.

In the present invention, the term “organic material” is a compoundcontaining a carbon atom, and comprised of mainly carbons and oxygens.Therefore, they are not particularly restricted so that it does notmatter whether they are artificially synthesized or extracted fromnatural substances. Illustrative example thereof includes biologicallyingestible substances such as drug compositions, foods, food additives,and health foods; polymers such as synthetic resins, synthetic fibers,and rubbers; coloring compounds such as dyes, pigments, and paints, andfragrances and agricultural chemicals. In the present invention, theorganic material microparticle means the microparticles of theabove-described organic materials.

The biologically ingestible substance is not particularly restricted sofar as the purpose thereof is to be ingested into a biological body.Illustrative example thereof includes those absorbed into a living bodyso as to express the effect thereof in the living body such as a drug ina pharmaceutical product, those passing through a living body and thendischarged therefrom, those transporting a drug component in a drugdelivery system, those applied to a skin of a living body such ascosmetics, as well as foods and intermediate bodies of these materials.Specifically, they are organic materials used in drugs, quasi-drugs,cosmetics, foods, food additives, health foods, etc. The biologicallyingestible substances of the present invention may be commerciallyavailable or newly synthesized.

Illustrative example of the ingestible substance includes: drugcompositions such as analgesic agents, anti-inflammatory agents,anthelmintic agents, antiarrhythmic agents, antibiotics, anticoagulants,antihypertensive drugs, antidiabetic agents, antiepileptic drugs,antihistaminic agents, anti-malignant tumor agents, anorectic drugs,anti-obesity drugs, antimuscarinic drugs, antimycobacterial agents,antineoplastic agents, immunosuppressive agents, antithyroid agents,antibacterial agents, antiviral agents, anti-anxiety drugs, astringents,beta-adrenoceptor blockers, blood derivatives, plasma substitutes,myocardial inotropic agents, contrast media, corticosteroids, coughsuppressants, diagnostic agents, diagnostic image-forming agents,diuretic agents, dopaminergic agents, hemostatic drugs, immunologicalagents, lipid regulatory agents, muscle relaxants, parasympathomimeticagents, parathyroid calcitonin, bisphosphonates, prostaglandins,radioactive agents, sex hormones, antiallergic agents, stimulants,anorexigenic agents, sympathomimetics, thyroid agents, vasodilators,xanthines, cataract remedies, adrenal corticosteroids, and allergicrhinitis drugs; food nutrient supplements such as nutritiously effectivesubstances, vitamins, minerals, and herbs; foods or food additives suchas folic acid, aliphatic acids, extracts of fruits and vegetables,vitamin supplements, mineral supplements, phosphatidyl serine, lipoicacid, melatonin, glucosamine/chondroitin, Aloe vera, guggle, glutamine,amino acids, green tea, and lycopene, and beauty-assisting foods such asherbs, plant nutrients, antioxidants, fruit flavonoids, collagens,hyaluronic acid, amino acids, vitamin C derivatives, and hydroquinones,though not limited to them. Included as the preferable propertiesthereof are a low solubility and a capacity of being administered orallyor by injection.

Illustrative example of the drug includes danazol, tacrolimus hydrate,progesterone, indomethacin, curcumin, tranilast, benzbromarone,naproxen, phenytoin, carotene, piposaru pham, piposarufan, camptothecin,acetaminophen, acetylsalicylic acid, amiodarone, colestyhumin,colestipol, cromolyn sodium, albuterol, sucralfate, sulfasalazine,minoxidil, temazepam, alprazolam, propoxyphene, auranofin, erythromycin,cyclosporine, aciclovir, ganciclovir, etoposide, mephalan, methotrexate,mitoxantrone, daunorubicin, doxorubicin, megestrol, tamoxifen,medroxyprogesterone, nystatin, terbutaline, amphotericin B, aspirin,ibuprofen, diclofenac, ketoprofen, flurbiprofen, diflumisal, diosgenin,cilostazol, tolbutamide, peptide, sodium cromoglicate, and pirenoxine.

Illustrative example of the quasi-drug includes teeth pastes, medicinalcosmetics, hair growth agents, mouth fresheners, and bad breathprevention agents.

Illustrative example of the cosmetic includes basic skin-care cosmeticssuch as skin lotion, milky lotion, and toning lotion, as well assunscreen cosmetics, make-up cosmetics, hair cosmetics, cleaningcosmetics, lip cosmetics, mouth cosmetics, nail cosmetics, eyelinercosmetics, and bathing cosmetics.

Illustrative example of the food or the food additive includes vitaminssuch as vitamins A, B, C, E, etc., or derivatives thereof, as well asamino acids, carotenoids, and extracts from fruits and plants.

Illustrative example of the health food includes coenzyme Q 10, as wellas vitamins such as vitamins A, B, C, E, etc., or derivatives thereof.These may be used singly or as a mixture of two or more of them.

In the present invention, there is no particular restriction in theresin. Illustrative example thereof includes thermoplastic resins(condensed thermoplastic resins such as polyester resins, polyamideresin, polyurethane resins, poly(thio)ether resins, polycarbonateresins, polysulfone resins, and polyimide resins; vinyl polymerthermoplastic resins such as poly olefin resins, (meth)acryl resins,styrene resins, and vinyl resins; thermoplastic elastomers;nature-originated resins such as cellulose derivatives; andthermoplastic silicone resins), as well as thermosetting resins (such asepoxy resins, unsaturated polyester resins, diallyl phthalate resins,and silicone resins (silicone rubber and silicone varnish)). Theseresins may be used singly or as a combination of two or more of them.Usually, thermoplastic resins and water-insoluble resins (or hydrophobicresins, water-insoluble thermoplastic resins, etc.) are preferably used.

As for the polyester resins, various resins using a dicarboxylic acidcomponent, a diol component, an oxycarboxylic acid, and a lactone may beused. Illustrative example of the polyester includes polyC2-6alkylene-arylate resins such as polyethylene terephthalate,polytrimethylene terephthalate, polypropylene terephthalate,polybutylene terephthalate, poly 1,4-cyclohexyldimethyleneterephthalate, polyethylene naphthalate, and polybutylene naphthalate;copolyesters containing a C2-6 alkylene-arylate unit as a main component(for example, 50% or more by weight) (copolyesters having copolymercomponents of, for example, polyoxy C2-4 alkylene glycols having anoxyalkylene unit. C6-12 aliphatic dicarboxylic acids, and asymmetricaromatic dicarboxylic acids such as isophthalic acid and phthalic acid);aromatic polyester resins such as polyarylate resins and liquid crystalpolyesters; polyC2-6 alkyleneglycol C2-10 aliphatic dicarboxylate esterssuch as polyC2-6 alkylene oxalate, polyC2-6 alkylene succinate, andpolyC2-6 alkylene adipate; polyoxycarboxylic acid resins (for example,polyglycolic acid, polylactic acid, and glycolic acid-lactic acidcopolymer); polylactone resins (for example, polyC3-12 lactone resinssuch as polycaprolactone); and copolyesters of them (for example,polycaprolacone-polybutylene succinate copolymer resin). These polyesterresins may contain a urethane bond. In addition, theses polyester resinsmay be biologically degradable.

Illustrative example of the polyamide resin includes aliphatic polyamideresins, alicyclic polyamide resins, and aromatic polyamide resins,wherein aliphatic polyamide resins are usually used. These polyamideresins may be used singly or as a combination of two or more of them.Illustrative example of the aliphatic polyamide resin includescondensation products (for example, polyamide 46, polyamide 66,polyamide 610, polyamide 612, polyamide 1010, polyamide 1012, andpolyamide 1212) formed of an aliphatic diamine component (C4-10 alkylenediamines such as tetramethylene diamine and hexamethylene diamine) andan aliphatic dicarboxylic acid component (C4-20 alkylene dicarboxylicacids such as adipic acid, sebacic acid, and dodecane dicarboxylicacid); homopolymers or copolymers (for example, polyamide 6, polyamide11, polyamide 12, polyamide 6/11, and polyamide 6/12) formed of a lactam(C4-20 lactams such as ε-caprolactam and ω-laurolactam) or an aminocarboxylic acid (C4-20 amino carboxylic acids such as ω-amino undecanoicacid); and copolyamides formed by copolymerization of these polyamidecomponents (for example, polyamide 66/11 and polyamide 66/12). Thedicarboxylic acid component in the polyamide resins may contain a dimeracid unit. Further, the polyamide resins may be biologically degradable.

As for the ether resins, especially poly(thio)ether resins, illustrativeexample thereof includes polyoxyalkylene resins (stabilizedpolyoxymethylene glycol or homo or copolyacetal resins, and polyoxy C2-4alkylene glycols such as polyoxypropylene glycol, polyoxytetramethyleneglycol, and polyoxyethylene-polyoxypropylene block copolymer),polyphenylene ether resins, polyphenylene ether ketone resins,polysulfide resins (polythioether resins such as polyphenylene sulfideor copolymers thereof), and polyether ketone resins (such as polyetherether ketone resins).

The polyolefin resins are exemplified by homopolymers or copolymers ofα-C2-6 olefins, wherein illustrative example thereof includeshomopolymers or copolymers of olefins such as polyethylene,polypropylene, ethylene-propylene copolymer, and polymethylpentene-1;copolymers of an olefin and a copolymerizable monomer (such asethylene-vinyl acetate copolymer, ethylene-(meth)acrylic acid copolymersand ethylene-(meth)acrylate ester copolymers). These polyolefin resinsmay be used singly or as a combination of two or more of them.

As for the vinyl resins, illustrative example of the halogen-containingvinyl resin includes polyvinyl chloride resins, vinyl chloride-vinylacetate copolymer, vinylidene chloride resins, and fluorine-containingresins.

Illustrative example of the other vinyl resin or the derivative thereofincludes homopolymers or copolymers of vinyl carboxylate esters (such aspolyvinyl acetate and ethylene-vinyl acetate copolymer), saponificationproducts thereof (polyvinyl alcohol resins such as polyvinyl alcohol andethylene-vinyl alcohol copolymer), derivatives from the saponificationproducts (vinyl alcohol resins) (for example, polyvinyl acetal resinssuch as polyvinyl formal and polyvinyl butyral). In the ethylene-vinylalcohol copolymers, content of ethylene may be in the range of about 5to 40% by weight.

The present invention may be applied to various pigments that can beprovided and produced as the organic pigment.

For example, as for the red pigment of the present invention,commercially available pigments or newly synthesized pigments may beused. Illustrative example thereof includes pigments that are classifiedto C. I. Pigment Red in the color index, and part of the pigments thatare classified to C. I. Pigment Violet and to C. I. Pigment Orange. Morespecific example thereof includes quinacridone pigments such as C. I.Pigment Red 122 and C. I. Pigment Violet 19; diketo pyrrolo pyrrolepigments such as C. I. Pigment Red 254 and C. I. Pigment Orange 73;naphthol pigments such as C. I. Pigment Red 150 and C. I. Pigment Red170; perylene pigments such as C. I. Pigment Red 123; and azo pigmentssuch as C. I. Pigment Red 144.

In addition, the present invention may be applied to blue organicpigments. These blue organic pigments include organic pigments havingblueish colors such as blue, deep blue, and cyan.

As for the blue organic pigment of the present invention, commerciallyavailable pigments or newly synthesized pigments may be used.Illustrative example thereof includes pigments that are classified to C.I. Pigment Blue. More specific example thereof includes C. I. PigmentBlue-1, C. I. Pigment Blue-2, C. I. Pigment Blue-3, C. I. PigmentBlue-15, C. I. Pigment Blue-15:2, C. I. Pigment Blue-15:3. C. I. PigmentBlue-15.4, C. I. Pigment Blue-16, C. I. Pigment Blue-22, C. I. PigmentBlue-60, and C. I. Pigment Blue-75. These may be used singly or as amixture of two or more of them.

As for the organic pigment of the present invention, a compositephthalocyanine microparticle may also be used. Many kinds of thecomposite phthalocyanine microparticle have been provided and sold untiltoday, so that they may be used. Alternatively, they may also be newlysynthesized.

Especially, the applicant of the present invention developed thecomposite phthalocyanine microparticles, such as a copper-titanylphthalocyanine microparticle, a copper-cobalt phthalocyaninemicroparticle, and a copper-titanyl-cobalt phthalocyanine microparticle,these being optimal as coloring materials such as the pigment having thecrystal growth thereof suppressed and satisfying the requiredcharacteristics with the size of nanometers, preferably 100 nm or less.Further, the present applicant also developed the method for producingthe same. The composite phthalocyanine microparticles obtained by thismethod may also be used in the present invention.

Hereunder, this new composite phthalocyanine microparticle will beexplained. The method for producing the composite phthalocyaninemicroparticle comprises: a step 0 in which as raw materials at least acopper phthalocyanine and a titanyl phthalocyanine and/or a cobaltphthalocyanine are dissolved in a first solvent to obtain a dissolvedsolution; a step 1 in which the dissolved solution obtained in the step0 is mixed with a second solvent capable of being a poor solvent to theraw materials thereby effecting separation of the compositephthalocyanine; and a step 2 in which an organic solvent is made to actto the composite phthalocyanine obtained in the step 1.

The organic solvent is preferably a solvent based on an aromaticcompound or a solvent based on a heterocyclic compound; and for example,the organic solvent is preferably at least one solvent selected from thegroup consisting of styrene, xylene, toluene, benzene, cresol, cumene,and tetrahydrofuran. When the solvent based on an aromatic compound oron an alicyclic compound that can induce or facilitate the crystaltransition from an alpha-type copper phthalocyanine to a beta-typecrystal structure or the like which is usually more stable than thealpha-type is used as the organic solvent, surprisingly the crystaltransition to the more stable beta-type crystal structure or the likecan be suppressed; and on top of it, the crystal growth can besuppressed.

Also, the present invention may be executed such that a mixing weightratio of the raw materials (copper phthalocyanine/titanyl phthalocyanineand/or copper phthalocyanine/cobalt phthalocyanine) in the step 0 is ina range of 1 or more to less than 20. Further, the present invention maybe executed such that the titanyl phthalocyanine and the cobaltphthalocyanine are simultaneously or successively dissolved in the step0.

Similarly to the step 1 of the present invention mentioned before, theabove-mentioned step 1 may be executed by using a microreactor in whichat least two fluids to be processed are made to react with each other.

Also, the present invention may be executed such that both the compositephthalocyanine obtained in the step 1 and the composite phthalocyanineobtained in the step 2 are of the same crystal type. That is to say,even if the organic solvent is made to act to the compositephthalocyanine obtained in the step 1, the crystal transition does nottake place in the step 2. Also, a surfactant or a dispersant is added inthe organic solvent.

In the composite phthalocyanine microparticle, it is suitable that theaspect ratio thereof is in a range of 1.1 to 2.5 (both inclusive) andthe particle diameter thereof is in a range of 5 to 100 nm (bothinclusive). The above-mentioned aspect ratio is defined as the ratio ofa long side to a short side in each composite phthalocyaninemicroparticle such as the copper-titanyl phthalocyanine microparticle.For example, if the shape thereof can be regarded as a cuboid shape or aquasi-cuboid shape, this is defined as the ratio of the longest side tothe shortest side of the three sides thereof. If the shape thereof canbe regarded as a sphere shape or a quasi-sphere shape, this is definedas the ratio of the longest diameter to the shortest diameter. Also, forexample, the aspect ratio is defined as an average value of the longdiameters to the short diameters of 100 particles measured with anobservation by using a transmission electron microscopy (TEM).

The present invention may be executed such that a relative value([Abs(a)]/[Abs(b)]) is 0.8 or more, wherein Abs (a) is defined as “Abs”at the peak top in the range of 655 to 700 nm of an absorption spectrumof the composite phthalocyanine microparticle in a UV-visible region andAbs (b) is defined as “Abs” at the peak top in the range of 550 to 640nm of the same. The above-mentioned “Abs” is defined as the absorbancemeasured in the UV-visible absorption spectrum and calculated on thebasis of the Lambert-Beer's law; and “Abs” at the peak top is defined asthe maximum value among “Abs” in a specified wavelength range.

As for the surfactant of the present invention, various commerciallyavailable products shown below, or newly synthesized surfactants may beused. Although there is no particular restriction, illustrative examplethereof includes anionic surfactants, cationic surfactants, nonionicsurfactants, and amphoteric surfactants, as well as dispersants such asvarious polymers. Depending on the use thereof, the surfactant to beused can be restricted. For example, in the case of biologicallyingestible substances, poisonous characters and the like to a livingbody need to be taken into consideration. Though not to limit to thefollowing, illustrative example of the surfactant includes those basedon dodecylbenzenesulfonic acid such as Neogen R-K (manufactured byDai-Ichi Kogyo Seiyaku Co., Ltd.); Solsperse 20000, Solsperse 24000,Solsperse 26000, Solsperse 27000, Solsperse 28000, and Solsperse 41090(all manufactured by Avecia Corp.); BYK 108, Disperbyk 160, Disperbyk161, Disperbyk 162. Disperbyk 163, Disperbyk 166, Disperbyk 170,Disperbyk 180. Disperbyk 181, Disperbyk 182, Disperbyk 183, Disperbyk184, Disperbyk 190, Disperbyk 191, Disperbyk 192, Disperbyk 2000,Disperbyk 2001, Disperbyk 2163, and Disperbyk 2164 (all manufactured byBYK-Chemie); Polymer 100, Polymer 120, Polymer 150, Polymer 400, Polymer401, Polymer 402, Polymer 403, Polymer 450, Polymer 451, Polymer 452,Polymer 453, EFKA-46, EFKA-47, EFKA-48, EFKA-49, EFKA-1501, EFKA-1502,EFKA-4540, and EFKA-4550 (all manufactured by EFKA Chemical Corp.);Kaosera 2000, Pelex TG, and Pelex TR (all manufactured by Kao Corp.);Flowlen DOPA-158, Flowlen DOPA-22, Flowlen DOPA-17, Flowlen G-700,FlowlenTG-720W, Flowlen-730W, Flowlen-740W, and Flowlen-745W (allmanufactured by Kyoeisha Chemical Co., Ltd.); Ajisper PA 111. AjisperPB711, Ajisper PB811, Ajisper PB821, and Ajisper PW911 (all manufacturedby Ajinomoto Co., Inc.); Johncryl 678, Johncryl 679, and Joncryl 62 (allmanufactured by Johnson Polymer B.V.); celluloses such as hydroxymethylcellulose, hydroxyethyl cellulose, hydroxypropyl cellulose,hydroxypropylmethyl cellulose, carboxymethyl cellulose, sodiumcarboxymethyl cellulose, methyl cellulose, and ethyl cellulose; polymerssuch as polyvinyl alcohol; lipids such as polyvinyl pyrrolidone,lecithin, and cholesterol; sulfonium compounds; plant resins such asArabic gum and Ghatti gum; gelatin, casein, phosphatide, dextran,glycerol, tragacanth, stearic acid, benzalkonium chloride, calciumstearate, glycerol monostearate, cetostearyl alcohol, and cetomacrogolemulsified wax; sorbitan esters such as Span 80, Span 60, and Span 20;polyoxyethylene alkyl ethers and polyoxyethylene castor oil derivative;polyoxyethylene sorbitan fatty acid esters such as Tween 80, Tween 60,Tween 40, and Tween 20; polyethylene glycol, dodecyl trimethyl ammoniumbromide, polyoxyethylene stearate, colloidal silicon dioxide,phosphates, sodium dodecylsulfate, and4-(1,1,3,3-tetramethylbutyl)-phenol polymer with ethylene oxide andformaldehyde; poloxamers such as Lutrol F127, Lutrol F108, Futrol F87,and Futrol F68; poloxamines; charged lipids and dioctyl sulfosuccinate;dialkyl esters of sodium sulfosuccinic acid; sodium laurylsulfate, alkylaryl polyether sulfonates, a mixture of sucrose stearate and sucrosedistearate, p-isononyl phenoxy polyglycidol, decanoyl-N-methylglucamide,n-decyl β-D-glucopyranoside, n-decyl β-D-maltopyranoside, n-dodecylβ-D-glucopyranoside, n-dodecyl β-D-maltoside, heptanoyl-N-methylglucamide, n-heptyl β-D-glucopyranoside, n-heptyl β-D-thioglycoside,n-hexyl β-D-glucopyranoside, nonanoyl-N-methyl glucamide, n-noylβ-D-glucopyranoside, octanoyl-N-methyl glucamide, n-octylβ-D-glucopyranoside, octyl β-D-thioglucopyranoside, lysozyme,PEG-lipids, PEG-cholesterol, PEG-cholesterol derivatives, PEG-vitamin A,random copolymer of vinyl acetate and vinyl pyrrolidone, quaternaryammonium compounds, benzyl-di(2-chloroethyl) ethyl ammonium bromide,coconut trimethyl ammonium chloride, coconut trimethyl ammonium bromide,coconut methyl dihydroxyethyl ammonium chloride, coconut methyldihydroxyethyl ammonium bromide, decyl triethyl ammonium chloride, decyldimethyl hydroxyethyl ammonium chloride, decyl dimethyl hydroxyethylammonium chloride bromide, C12-15 dimethyl hydroxyethyl ammoniumchlorides, C12-15 dimethyl hydroxyethyl ammonium chloride bromides,coconut dimethyl hydroxyethyl ammonium chloride, coconut dimethylhydroxyethyl ammonium bromide, myristyl trimethyl ammonium sulfate,lauryl dimethyl benzyl ammonium chloride, lauryl dimethyl benzylammonium bromide, lauryl dimethyl (ethenoxy) 4 ammonium chloride, lauryldimethyl (ethenoxy) 4 ammonium bromide, N-alkyl (C12-18)dimethylbenzylammonium chlorides, N-alkyl (C14-18)dimethylbenzyl ammonium chlorides,N-tetradecyldimethylbenzyl ammonium chloride monohydrate, dimethyldidecyl ammonium chloride, N-alkyl and (C12-14) dimethyl 1-napthylmethylammonium chlorides, trimethylammonium halides, alkyltrimethylammoniumsalts, dialkyldimethylammonium salts, lauryl trimethyl ammoniumchloride, ethoxylated alkylamido alkyldialkyl ammonium salts,ethoxylated trialkyl ammonium salts, dialkylbenzene dialkylammoniumchlorides, N-didecyldimethyl ammonium chloride,N-tetradecyldimethylbenzyl ammonium, chloride monohydrate,N-alkyl(C12-14) dimethyl 1-naphthylmethyl ammonium chlorides,dodecyldimethylbenzyl ammonium chloride, dialkyl benzenealkyl ammoniumchlorides, lauryl trimethyl ammonium chloride, alkylbenzyl methylammonium chlorides, alkyl benzyl dimethyl ammonium bromides, C12trimethyl ammonium bromides, C15 trimethyl ammonium bromides, C17trimethyl ammonium bromides, dodecylbenzyl triethyl ammonium chloride,poly-diallyldimethylammonium chloride (DADMAC), dimethyl ammoniumchloride, alkyldimethyl ammonium halides, tricetyl methyl ammoniumchloride, decyltrimethyl ammonium bromide, dodecyltriethyl ammoniumbromide, tetradecyltrimethyl ammonium bromide, methyl trioctyl ammoniumchloride, POLYQUAT 10™, tetrabutyl ammonium bromide, benzyl trimethylammonium bromide, choline esters, stearalkonium chloride compounds,cetyl pyridinium bromide, cetyl pyridinium chloride, halide salts ofquaternized polyoxyethylalkylamines, MIRAPOL™, ALKAQUAT™, alkylpyridinium salts, amines, amine salts, amine oxides, imide azoliniumsalts, protonated quaternary acrylamides, and methylated quaternarypolymers. These may be used singly, or two or more of them may beconcurrently used.

In the cases that the organic material microparticles are oflow-molecular weight organic materials shown in Examples A, such as, forexample, indomethacin, curcumin, and pirenoxine, though not limited tothese cases, it is preferable to use polymer surfactants such aswater-soluble nitrogen-containing vinyl polymers and nonionic cellulosederivatives. More specific illustrative example thereof includeshydroxypropyl cellulose, hydroxyethyl cellulose, carboxymethylcellulose, methyl cellulose, polyvinyl alcohol, and polyvinylpyrrolidone. In addition, there are cases that nonionic surfactants suchas Tween 80 and polyoxyethylene-hardened castor oil can be effective inview of dispersibility, so that it is also preferable to use themtogether with the polymer surfactant. In the cases that the organicmaterial microparticles are of organic materials of the pigments shownin Examples B and C, it is preferable to use polymer surfactants such asan acryl polymer and a high-molecular weight block copolymer,surfactants such as a hydroxyl-group containing carboxylate ester, andanionic surfactants such as a sodium dialkylsulfo succinate and a sodiumdodecylbenzenesulfonate.

In the organic material microparticle of the present invention, apolymer surfactant of a block copolymer may be used as well. In thiscase, illustrative example of the block copolymer includes acrylic ormethacrylic block copolymers, block copolymers of polystyrene and otheraddition polymerization or condensation polymerization block, and blockcopolymers having the blocks of polyoxyethylene and polyoxyalkylene.Conventionally known block copolymers may also be used. The blockcopolymer to be used in the present invention is preferably amphiphilic.Specific preferable forms include diblock copolymers having ahydrophobic segment and a hydrophilic segment having an organic acid orits ionic salt unit. Also, triblock copolymers having a hydrophobicsegment, a hydrophilic segment having an organic acid or its ionic saltunit, and another segment are preferably used. The triblock copolymersare used preferably in the form having a hydrophobic segment, a nonionichydrophilic segment, and a hydrophilic segment having an organic acid orits ionic salt unit; and these are also preferably used forstabilization of their inclusion state. For example, when the triblockcopolymer described above is used to prepare a dispersion solution usingan organic material such as a pigment material and water as a solvent,the organic material such as the pigment can be included in micellesformed by the triblock copolymer. In addition, the particle diameter ofthe particles in the dispersion composition can be made very even anduniform. Further, the dispersed state thereof can be made highly stable,too.

As for the solvent to be used in the present invention, various solventsmay be used in order to dissolve the raw materials of the organicmaterial microparticle, to separate the organic material microparticlefrom the raw material solution of the organic material microparticle,and to control the properties of the organic material microparticle byadding the surfactant to be described later. Illustrative example of thesolvent includes water (distilled water, purified water, etc.) andorganic solvents (alcohol-based solvents, ketone-based solvents,ether-based solvents, aromatic-based solvents, aliphatichydrocarbon-based solvents, nitrile-based solvents, sulfoxide-basedsolvents, halogen-based solvents, ester-based solvents, amine-basedsolvents, and ionic solutions). These solvents may be used by selectingone, or two or more solvents as a mixture thereof, in accordance withthe aim of the embodiment. In addition, as the case may be, pH of thesolution may be controlled by adding an acidic substance or a basicsubstance to these various solvents.

The above-mentioned solvents will be explained more specifically.Illustrative example of the alcohol-based solvent includes methanol,ethanol, isopropanol, n-propanol, 1-methoxy-2-propanol (PGME); linearalcohols such as n-butanol; branched alcohols such as 2-butanol andtert-butanol; and polyvalent alcohols such as ethylene glycol anddiethylene glycol. Illustrative example of the ketone-based solventincludes acetone, methyl ethyl ketone, and cyclohexanone. Illustrativeexample of the ether-based solvent includes dimethyl ether, diethylether, and tetrahydrofuran. Illustrative example of the aromatic-basedsolvent includes styrene, toluene, xylene, phenol, nitrobenzene,chlorobenzene, dichlorobenzene, tetrahydrofuran, and pyridine.Illustrative example of the aliphatic-based solvent includes pentane,hexane heptane, octane, and cyclohexane. Illustrative example of thenitrile-based solvent includes acetonitrile. Illustrative example of thesulfoxide-based solvent includes dimethyl sulfoxide, diethyl sulfoxide,hexamethylene sulfoxide, and sulfolane. Illustrative example of thehalogen-based solvent includes chloroform, dichloromethane,trichloroethylene, and iodoform. Illustrative example of the ester-basedsolvent includes ethyl acetate, butyl acetate, methyl lactate, ethyllactate, and propylene glycol monomethyl ether acetate (PGMEA).Illustrative example of the ionic liquid includes benzyl trimethylammonium hydroxide (BTMA) and a salt of 1-butyl-3-methylimidazolium andPF6 (hexafluorophosphate ion). Illustrative example of the amine-basedsolvent includes dimethylamino ethanol, ethylenediamine, methylamine,dimethylamine, trimethylamine, ethylamine, diethylamine, andtriethylamine. Illustrative example of the amide-based solvent includesN,N-dimethylformamide and N,N-dimethylacetamide.

“The solvent which has a partial dissolvability to the organic materialmicroparticle” in the present invention does not indicate a strongdissolvability to completely dissolve all of the organic materialmicroparticles from the time when the solvent is made to act to theorganic material microparticles till completion of this treatment, butdoes indicate such degree of dissolvability so as to cause some “change”in the properties of the microparticles. Hereinafter, this solvent isalso called as “the solvent having a partial dissolvability”. The term“change” used here is not particularly restricted, while illustrativeexample thereof includes the phenomenon that when the solvent is made toact to the organic material microparticles, part of the organic materialmicroparticles grows to cause coarsening thereof and the phenomenon thatthe organic material microparticles undergo necking with each other.

For example, solubility of the organic material microparticle to thesolvent having a partial dissolvability is preferably in the range of 1to 1000 μg/g both inclusive (in the range of 1 to 1000 ppm bothinclusive), while more preferably in the range of 1 to 500 μg/g bothinclusive (in the range of 1 to 500 ppm both inclusive), wherein thesolubility is measured by using the organic material microparticleshaving an average particle diameter of 1000 nm. Even if themicroparticles are not completely dissolved, if the solvent has too muchsolubility to the organic material microparticle, the particle growthand degree of coarsening of the particle become so high that applicationthereof to the present invention becomes difficult.

Meanwhile, the above-mentioned solubility is measured as follows. Afterthe organic material microparticles having an average particle diameterof 1000 nm are made to act to the solvent, the microparticles arefiltrated out through a filter having the pore diameter of about 0.1 to0.2 μm, and then, the filtrate thereof is subjected to the UV-Vismeasurement (visible-UV spectrophotometric measurement) so as tocalculate concentration of the organic material dissolved in thesolvent. Calculation of the concentration thereof may be made on thebasis of measurements by means of other detection method such asmeasurement with fluorescence or refractive index of the filtrate.

In combination of the organic material microparticle and the solventhaving a partial dissolvability, for example, when the organic materialmicroparticle is of indomethacin, curcumin, or pirenoxine, solvents tobe preferably used are linear alkanes such as pentane, hexane, heptane,octane, nonane, decane, and undecane, and cyclic alkanes such ascyclohexane, as well as water. For example, when the organic materialmicroparticle is of polypropylene, solvents to be preferably used arealcohol-based solvents such as methyl alcohol and isopropyl alcohol, aswell as aromatic-based solvents such as toluene and xylene.

For example, in FIG. 8 and FIG. 11 showing the results of ComparativeExamples A of the present invention, it was confirmed the way how theparticles grow in the solvent and cause necking. Once the state likethis is resulted, the particles cannot be dispersed even if thedispersion treatment is carried out thereafter; and thus, it is verydifficult to express the characteristics to be obtained by making theorganic material to microparticles (for example, change in physicalproperties such as improvement of solubility, change in the opticalproperties such as improvement of transparency, and change in chemicalproperties such as novel reaction, etc.).

As one other example, the TEM observation result of the red pigmentPR254 microparticles produced by Experiment No. 1-1 of Examples B of thepresent invention is shown in FIG. 31 , the picture being taken when thesaid microparticles are introduced into propylene glycol monomethylether acetate (PGMEA). Also, the TEM observation result of the samebefore the said microparticles are introduced thereinto is shown in FIG.29 (this is dispersed in the surfactant-containing aqueous solution). Itcan be confirmed that as compared with the PR254 nanoparticles shown inFIG. 29 , the PR254 nanoparticles shown in FIG. 31 grow in PGMEA andcause necking. Once the state like this is resulted, the nanoparticlesthereof cannot be dispersed even if the dispersion treatment is carriedout thereafter; and thus, it is very difficult to express the finecharacteristics of the red pigment.

Also, it can be confirmed that the copper-titanyl-cobalt phthalocyaninemicroparticle that is the blue pigment produced by Experiment No. 4-4 ofExamples C of the present invention (FIG. 36 ) or the copperphthalocyanine microparticle that is the blue pigment produced byExperiment No. 3-1 (FIG. 37 ) grows in the above-mentioned solvent andcauses necking, both microparticles being produced as further examples.Once the state like this is resulted, the particles thereof cannot bedispersed even if the dispersion treatment is carried out thereafter;and thus, it is very difficult to express the characteristics of theblue organic pigment microparticle.

In the present invention, it is important that the organic materialmicroparticle before being subjected to the action of the particleproperty control solution have an amorphous portion at least in partthereof, and that the solvent which has a partial dissolvability to theorganic material microparticle be daringly selected, and that theparticle property control solution that is prepared by adding thebefore-mentioned surfactant to the said solvent, specifically, bymixing, dissolving, or molecular-dispersing them be made to act to theorganic material microparticle. By so doing, properties of the organicmaterial microparticle, such as particle diameter, crystal type, andcrystallinity, can be controlled.

Although the controlling mechanism of the particle properties is notclear, molecules of the amorphous portion of the organic materialmicroparticle are randomly distributed in the solid state, and thereforethe molecules do not reside densely among them as compared with thecrystalline portion, so that binding forces among the molecules areweak. Presumably because of this, the amorphous portion of the organicmaterial microparticle is prone to dissolve by action of the solventwhich has a partial dissolvability to the organic materialmicroparticle, thereby readily generating starting points of growth andnecking of the said microparticles.

Although the organic material microparticle is prone to cause neckingand particle growth when part thereof is dissolved in the solvent by theeffects of the solvent and heat, if it is kept under such conditions,both the crystal transition and increase in the degree of crystallinitycan take place simultaneously. Such changes accompany the change of theprimary particle diameter of the organic material microparticle with themagnification of several tens to several hundreds; and therefore, theorganic material microparticle thus coarsened is resulted in loss of thecharacteristics expected as the organic material microparticle. Oneeffect of the surfactant in the present invention is to suppress andcontrol the growth of the organic material microparticle. Theabove-mentioned surfactant suppresses dissolution of the organicmaterial microparticle (especially the amorphous portion thereof) due tothe action of the solvent which has a partial dissolvability to theorganic material microparticle, so that the actions to the organicmaterial microparticle such as necking and particle growth can besuppressed and controlled. More specifically, presumably, in thepresence of the surfactant, the amorphous portion of the organicmaterial microparticle does not reach the state of complete dissolutionby the solvent having a partial dissolvability, but the random moleculararrangement of the amorphous portion thereof does change to causecompaction, thereby resulting in crystal transition and increase in thedegree of crystallinity.

Another effect of the surfactant is to increase in the dissolvability ofthe solvent to the organic material microparticle. More specifically,wettability of the entire particles after having been acted by thesurfactant can be enhanced. That is to say, the surfactant has an effectto give different properties to the organic material microparticle inaccordance with the kind thereof, combination thereof with the solvent,etc. Therefore, the particle property control solution may be preparedby adding the surfactant which can enhance the solubility of the saidsolvent to the organic material microparticle into the solvent which hasa partial dissolvability to the organic material microparticle. Furthereffect of the surfactant resides in that it can serve as the template atthe time of the change in the crystal type of the organic materialmicroparticle, more specifically, the template of the particle diameterof the organic material microparticle.

The present invention can be considered that by multiplying theabove-mentioned effects, especially the amorphous portion of the organicmaterial microparticle is made compact with controlling the growth ofthe organic material microparticle, so that the crystallinity thereof isenhanced thereby achieving the control of the crystal type transition aswell as the crystallinity thereof.

As described above, in the present invention, the particle propertiessuch as particle diameter, crystallinity, and crystal type of theorganic material microparticle is controlled by making the particleproperty control solution act to the organic material microparticle.Specifically, operation of the above-mentioned action includes mixing ofthe organic material microparticle with the particle property controlsolution and/or stirring them, and mere contacting or spraying of thesaid solution; with such operations, properties of the organic materialmicroparticle can be controlled by changing the kind of the solvent andsurfactant, the concentration of the solution, the treating temperature,the stirring method, etc. In addition, the solvent having a partialdissolvability can be prepared by containing an acidic substance, abasic substance, or a neutral substance to be described later in thesolvent.

These substances are not particularly restricted, while illustrativeexample of the acidic substance includes inorganic acids such as aquaregia, hydrochloric acid, nitric acid, fuming nitric acid, sulfuricacid, and fuming sulfuric acid; and organic acids such as formic acid,citric acid, malic acid, acetic acid, chloroacetic acid, dichloroaceticacid, oxalic acid, trifluoroacetic acid, and trichloroacetic acid.Illustrative example of the basic substance includes metal oxides suchas sodium hydroxide and potassium hydroxide; metal alkoxides such assodium methoxide and sodium isopropoxide; and amine compounds such astriethylamine, diethylamino ethanol, and diethylamine. Further, neutralsubstances such as slats of the acidic substances and the basicsubstances that are exemplified above may be mixed therewith.

Especially in the case of organic pigments such as the red organicpigment and blue organic pigment, the present invention can be executedwithout including a pigment derivative that is generally used in orderto suppress the crystal growth. Therefore, the merit that the colorinherent to the derivative does not affect the color development of theactually used organic pigment can be realized. However, the executionwith addition of such derivative is not excluded.

Meanwhile, the concentration of the organic material microparticle thatis to be acted to the solvent which has a partial dissolvability to theorganic material microparticle is not particularly restricted, while theconcentration thereof is generally in the range of 0.001 to 90.00% byweight, preferably in the range of 0.001 to 50.00% by weight, while morepreferably in the range of 0.01 to 40.00% by weight. The concentrationof the surfactant relative to the organic material microparticle isgenerally in the range of 0.01 to 500% by weight, preferably in therange of 0.1 to 300% by weight, while more preferably in the range of1.0 to 100% by weight.

In the present invention, there is no particular restriction in theparticle diameter of the organic material microparticle, while theparticle diameter of the organic material microparticle before controlof the particle properties of the organic material microparticle ispreferably in the range of 1000 nm or less, more preferably 500 nm orless, while still more preferably in the range of 200 nm or less.

In the organic pigments such as the blue organic pigment, the primaryparticle diameter of the fine particles is generally in the range of 500nm or less, preferably in the range of 100 nm or less, while still morepreferably 30 nm or less. The shape of the particle or the microparticleis not particularly restricted, while these may be particles or theaggregate having the shapes such as a quasi-cylindrical column, aquasi-sphere, a quasi-disk, a quasi-triangular prism, a quasi-squarepillar, a quasi-polygonal, and an elliptical sphere.

Meanwhile, the particle diameters measured before and after the actionof the present invention is defined as the particle diameters measuredbefore and after the operation such as mixing the organic materialmicroparticle with the particle property control solution and/orstirring them, and mere contacting or spraying of the said solution.

In the present invention, the range in which the particle diameter ofthe organic material microparticle does not substantially change isdefined as the range in which the rate of change in the particlediameter of the organic material microparticles measured before andafter the solvent having a partial dissolvability to the organicmaterial microparticle and having the surfactant added therein is madeto act to the organic material microparticle (after the surfactanttreatment (A)/before the surfactant treatment (B)) is 1 to 4.

The present invention comprises the step 1 in which, in order toseparate the organic material microparticle from the raw materialsolution of the organic material microparticle, a separating solvent Lfor separating at least one kind of the organic material particles ismixed with a raw material solution of the organic materialmicroparticle, this solution having the raw material of the organicmaterial microparticle dissolved or molecular-dispersed therein, therebyeffecting separation of the organic material microparticle (P1). The rawmaterial to be used for the organic material microparticle may be theorganic materials as described above as well as newly synthesizedmaterials. The above-mentioned mixing method may be, for example, theone using a microreactor with the type of a forced thin film asdescribed in Patent Document 5, or the mixing may be conducted byappropriately using publicly known methods in organic materialmicroparticles. The present invention may be executed in such a way thata good solvent capable of dissolving or molecular-dispersing the rawmaterial of the organic material microparticle is mixed with the saidraw material of the organic material microparticle so as to prepare theraw material solution, and a solvent having a lower solubility to theorganic material than the good solvent is used as the separating solventL of the organic material microparticle. Alternatively, the presentinvention may be executed by controlling a pH at the time of mixing ofthe raw material solution of the organic material microparticle with theseparating solvent L of the organic material microparticle. As the casemay be, by combining the solvent with an acidic substance or a basicsubstance, the pH may be controlled as well.

In addition, as the case may be, the present invention may comprise thestep c in which washing and/or solvent substitution is conducted to theorganic material microparticle (P1) obtained in the step 1. This step cin which washing and/or solvent substitution is conducted may beexecuted by using publicly known methods as appropriately. Though notparticularly restricted, to the solution containing the organic materialmicroparticle, washing and/or solvent substitution of the organicmaterial microparticle can be conducted by the operation such asfiltration, centrifugal separation, and ultrafiltration, with properselection of the solvent in accordance with the purpose thereof.

The present invention is characterized by that properties of the organicmaterial microparticle is controlled by including the step 2 in whichthe particle property control solution is made to act to the organicmaterial microparticle (P1). With regard to the property control,increase of the particle diameter of the organic material microparticleand/or enhancement of the crystallinity of the organic materialmicroparticle may be mentioned. With regard to the crystallinity of theorganic material microparticle, the degree of crystallinity of theorganic material microparticle may be mentioned. The property control ofthe particle referred herein is not limited to the above-mentionedcontent so far as growth of the particle in the solvent or necking canbe suppressed; and thus, this control includes the case that the organicmaterial microparticle undergoes the crystal transition. In addition, byseparating the microparticles in such a way that the crystallinitythereof may be low so as to contain the amorphous portion, particleproperties such as the crystal type and the degree of crystallinity canbe controlled more precisely in the step 2. By so doing, the presentinvention can be made more effective.

Illustrative example of the action in the step 2 includes mixing,contacting, and spraying. In the step 2 of the present invention, thesaid action may be conducted once, or plural times (for example, twice,three times, four times, etc.).

In the step 2 of the present invention, if a stirring treatment isincluded (hereunder, this treatment is sometimes referred to asdispersion treatment by stirring, or dispersion treatment), propertiesof the organic material microparticle can be controlled by means of astirring energy, wherein the stirring energy may be controlled with amethod using publicly known stirring equipment and stirring means.Meanwhile, detailed description of the stirring energy can be found inthe Japanese Patent Laid-Open Publication No. H04-114725 filed by thepresent applicant.

The stirring method of the present invention is not particularlyrestricted. The stirring may be conducted with a method using a magneticstirrer and a stirring bar. The stirring may also be conducted by usinga stirrer, a dissolver, an emulsifier, a disperser, a homogenizer, etc.with various shearing methods, a friction method, a high pressure jetmethod, an ultrasonic method, etc. Illustrative example thereof includescontinuous emulsifiers such as Ultra Turrax (manufactured by IKA Corp.),Polytron (manufactured by KINEMATICA AG), TK Homomixer (manufactured byPRIMIX Corp.). Ebara Milder (manufactured by EBARA Corp.), TK HomomicLine Flow (manufactured by PRIMIX Corp.), Colloid Mill (manufactured byShinko Pantech Co., Ltd.), Slusher (manufactured by Nippon Coke &Engineering Co., Ltd.), Trigonal Wet-Type Fine Grinding Mill(manufactured by Mitsui Miike Machinery Co., Ltd.). Cavitron(manufactured by Eurotech Co., Ltd.), and Fine Flow Mill (manufacturedby Pacific Machinery & Engineering Co., Ltd.); and batch or continuousapparatuses such as Clearmix (manufactured by M. Technique Co., Ltd.).Clearmix Dissolver (manufactured by M. Technique Co., Ltd.), ClearmixDouble Motion (manufactured by M. Technique Co., Ltd.), and Filmix(manufactured by PRIMIX Corp.). In addition, there is a case that apartial treatment with microwave before or after the stirring iseffective.

The particle growth can take place via two ways. Namely, in one case,particles aggregate among themselves and dissolve at the crystal surfacethereof, thereby leading to the growth and coarsening thereof, while inother case, coarsening of the particles takes place from a portion thatis dissolved in the dispersion medium. Effect of the surfactant is toprotect the particle surface so as to suppress the growth thereof,however, if the particles form aggregates, the surfactant cannoteffectively express its function in a certain case. Because of this, thedispersion treatment by stirring can be effective. In this method, thesurfactant is uniformly mixed for the reaction with the solvent whichhas a partial dissolvability to the organic material microparticle; andthus, it is preferable to carry out the stirring treatment. Further, atthe time when the particle property control solution is made to act tothe organic material microparticle, too, it is preferable to carry outthe stirring treatment. In this occasion, by the stirring energy appliedto the system, the surfactant as well as the solvent which has a partialdissolvability to the organic material microparticle can be made to actto the organic material microparticle effectively. In the case that thestirring treatment is included in the step 2, the properties of theorganic material microparticle (degree of crystallinity, crystal type,and particle diameter) can be controlled by means of the stirringenergy.

Hereinafter, as one example, the production process of the organicmaterial microparticle according to a batch method (step 0 to 2) will beexplained along FIG. 1 .

(Step 0)

The separating solvent of the organic material microparticle (Asolution: this corresponds to the separating solvent L of the organicmaterial microparticle) and the raw material solution of the organicmaterial microparticle (B solution) were prepared.

(Step 1)

Mixing of the A solution and B solution: the B solution was introducedinto the A solution with stirring the A solution by means of a magneticstirrer and a stirring bar so as to effect the separation of the organicmaterial microparticles.

(Step 2)

The slurry of the organic material microparticles separated in the step1, or the wet cake or the dried powder of the same was introduced intothe particle property control solution, and then, the resulting mixturewas subjected to the stirring treatment.

Alternatively, the embodiment may be employed wherein the slurrycontaining the organic material microparticles that are separated in thestep 1 is filtrated, followed by washing the microparticles with awashing solution (step c), and thereafter, the wet cake of the organicmaterial microparticles or the dried powder of the organic materialmicroparticles obtained by a drying treatment such as by a vacuum dryingmethod is produced, and then, the wet cake or the dried powder thusobtained is introduced into the particle property control solution inthe step 2 whereby carrying out the stirring treatment.

Next, hereinafter, as another example, the production process (step 0 to2) of the organic material microparticle by using a microreactor to bedescribed later will be explained along FIG. 1 .

(Step 0)

The separating solvent of the organic material microparticle (Asolution) and the raw material solution of the organic materialmicroparticle (B solution) were prepared.

(Step 1)

By using the microreactor shown in FIG. 2(A), the raw material solutionof the organic material microparticle (B solution) and the separatingsolvent of the organic material microparticle (A solution: thiscorresponds to the separating solvent L to separate the organic materialmicroparticle) were mixed so as to effect the separation of the organicmaterial microparticle. Meanwhile, as for the A solution and B solution,besides those exemplified in EXAMPELS to be described later, thosedescribed in Patent Document 8, as well as publicly known examples ofmixing and separation may be used.

(Step 2)

The slurry of the organic material microparticles separated in the step1, or the wet cake or the dried powder of the same was introduced intothe particle property control solution, and then, the resulting mixturewas subjected to the stirring treatment.

Alternatively, the embodiment may be employed wherein the slurrycontaining the organic material microparticles that are separated in thestep 1 is filtrated, followed by washing the microparticles with awashing solution (step c), and thereafter, the wet cake of the organicmaterial microparticles or the dried powder of the organic materialmicroparticles obtained by a drying treatment such as by a vacuum dryingmethod is produced, and then, the wet cake or the dried powder thusobtained is introduced into the particle property control solution inthe step 2 whereby carrying out the stirring treatment.

Meanwhile, as the microreactor, the one shown in FIG. 2 , which is thesame as the apparatuses described in Patent Document 4 to PatentDocument 6, can be used. Hereunder, the microreactor will be describedin detail. In FIG. 2(A), FIG. 2(B), and FIG. 3 , the reference characterR indicates a rotational direction.

The microreactor of the present embodiment is provided with twoprocessing members of a first processing member 10 and a secondprocessing member 20 arranged opposite to each other, wherein the firstprocessing member 10 rotates. The surfaces arranged opposite to eachother of the respective processing members 10 and 20 are made to be therespective processing surfaces. This apparatus is the microreactor withthe type of a forced thin film, wherein the first processing member 10is provided with a first processing surface 1 and the second processingmember 20 is provided with a second processing surface 2.

Each of the processing surfaces 1 and 2 is connected to a flow path d1and a flow path d2 of the fluids to be processed, respectively, therebyconstituting part of the flow paths of the fluids to be processed.Distance between these processing surfaces 1 and 2 is controlled so asto form a minute space usually in the range of 1 mm or less, forexample, in the range of about 0.1 to 50 sm. With this, the fluids to beprocessed passing through between the processing surfaces 1 and 2 becomea forced thin film fluid forced by the processing surfaces 1 and 2.

Then, this apparatus performs a fluid processing in which the first andsecond fluids to be processed are made to react with each other so as toseparate the microparticles between the processing surfaces 1 and 2.

To more specifically explain, this apparatus is provided with a firstholder 11 for holding the first processing member 10, a second holder 21for holding the second processing member 20, a surface-approachingpressure imparting mechanism 43, a rotation drive mechanism (not shownin drawings), a first introduction part d1, a second introduction partd2, a fluid pressure imparting mechanism p1, and a fluid pressureimparting mechanism p2. The fluid pressure imparting mechanisms p1 andp2 can be compressors or other pumps.

In the above-mentioned embodiment, the first processing member 10 andthe second processing member 20 are disks with ring forms. Material ofthe processing members 10 and 20 can be not only metal but also carbon,ceramics, sintered metal, abrasion-resistant steel, sapphire, and othermetal subjected to hardening treatment, and rigid material subjected tolining, coating, plating, or the like. In the processing members 10 and20 of the above-mentioned embodiment, the first and the second surfaces1 and 2 arranged opposite to each other are mirror-polished, and anarithmetic average roughness thereof is in the range of 0.01 to 1.0 μm.

In the above-mentioned embodiment, the second holder 21 is fixed to theapparatus, wherein the first holder 11 attached to a rotary shaft of therotation drive mechanism fixed to the same apparatus rotates, andthereby the first processing member 10 attached to this first holder 11rotates relative to the second processing member 20. As a matter ofcourse, the second processing member 20 may be made to rotate, or theboth may be made to rotate. In the present invention, the rotation canbe set to a speed of, for example, in the range of 350 to 3600 rpm.

In the above-mentioned embodiment, the second processing member 20approaches to and separates from the first processing member 10 in thedirection of the rotary shaft 50, wherein a side of the secondprocessing member 20 opposite to the second processing surface 2 isaccepted in an accepting part 41 arranged in the second holder 21 so asto be able to rise and set. However, in contrast to the above, the firstprocessing member 10 may approach to and separate from the secondprocessing member 20, or both the processing members 10 and 20 mayapproach to and separate from each other.

The above-mentioned accepting part 41 is a concave portion for acceptingthe side of the second processing member 20 opposite to the secondprocessing surface 2, and this concave portion is a groove being formedinto a ring. This accepting part 41 accepts the second processing member20 with sufficient clearance so that the side of the second processingmember 20 opposite to the second processing surface 2 may rise and set.

The surface-approaching pressure imparting mechanism is a mechanism togenerate a force (hereinafter, surface-approaching pressure) to pressthe first processing surface 1 of the first processing member 10 and thesecond processing surface 2 of the second processing member 20 in thedirection to make them approach each other. The mechanism generates athin film fluid having minute thickness in a level of nanometer ormicrometer while keeping the distance between the processing surfaces 1and 2 in a predetermined minute distance by the balance between thesurface-approaching pressure and the force due to the fluid pressure toseparate the processing surfaces 1 and 2 from each other. In theabove-mentioned embodiment, the surface-approaching pressure impartingmechanism supplies the surface-approaching pressure by biasing thesecond processing member 20 toward the first processing member 10 by aspring 43 arranged in the second holder 21. In addition, the first fluidto be processed which is pressurized with the fluid pressure impartingmechanism p1 is introduced from the first introduction part d1 into thespace inside the processing members 10 and 20.

On the other hand, the second fluid to be processed which is pressurizedwith the fluid pressure imparting mechanism p2 is introduced from thesecond introduction part d2 via a path arranged inside the secondprocessing member 20 to the space inside the processing members 10 and20 through an opening d20 formed in the second processing surface.

At the opening d20, the first fluid to be processed and the second fluidto be processed converge and mix with each other. At this time, themixed fluid to be processed becomes a forced thin film fluid by theprocessing surfaces 1 and 2 that keep the minute space therebetween,whereby the fluid is forced to move out from the circular, processingsurfaces 1 and 2. The first processing member 10 is rotating; and thus,the mixed fluid to be processed does not move linearly from inside thecircular, processing surfaces 1 and 2 to outside thereof, but does movespirally from the inside to the outside thereof by a resultant vectoracting on the fluid to be processed, the vector being composed of amoving vector toward the radius direction of the circle and a movingvector toward the circumferential direction.

Here, as shown in FIG. 3 , in the first processing surface 1 of thefirst processing member 10, a groove-like depression 13 extended towardan outer side from the central part of the first processing member 10,namely in a radius direction, may be formed. The depression 13 may be,as a plane view, curved or spirally extended on the first processingsurface 1, or, though not shown in the drawing, may be extended straightradially, or bent at a right angle, or jogged; and the concave portionmay be continuous, intermittent, or branched. In addition, thisdepression 13 may be formed also on the second processing surface 2, oron both the first and second processing surfaces 1 and 2. By forming thedepression 13 in the manner as mentioned above, the micro-pump effectcan be obtained so that the fluid to be processed may be sucked intobetween the first and second processing surfaces 1 and 2.

It is preferable that the base edge of the depression 13 reach the innerperiphery of the first processing member 10. The front edge of thedepression 13 is extended to the direction of the outer periphery of thefirst processing surface 1; the depth thereof is made graduallyshallower (smaller) from the base edge to the front edge. Between thefront edge of the depression 13 and the outer peripheral of the firstprocessing surface 1 is formed a flat plane not having the depression13.

The opening d20 described above is arranged preferably in a positionopposite to the flat surface of the first processing surface 1. By sodoing, mixing of a plurality of fluids to be processed and separation ofthe microparticles therefrom can be effected under the condition of alaminar flow.

In addition, the fluid discharged to outside the processing members 10and 20 is collected via a vessel v into a beaker b as a dischargedsolution. In the embodiment of the present invention, the dischargedsolution contains the organic material microparticles, as to bedescribed later.

In example A shown in FIG. 2(A), although kinds of the fluid to beprocessed and numbers of the flow path are set two respectively, theymay be three or more. The opening for introduction arranged in eachprocessing member is not particularly restricted in its form, size, andnumber; and these may be changed as appropriate. The opening forintroduction may be arranged just before the first and second processingsurfaces 1 and 2 or in the side of further upstream thereof.

In the present invention, it is good enough only if the processing couldbe effected between the processing surfaces 1 and 2, and an embodimentmay also be employed wherein the second fluid to be processed isintroduced from the first introduction part d1 and the first fluid to beprocessed is introduced from the second introduction part d2. Forexample, the expression “first” or “second” for each fluid has a meaningfor merely discriminating an n^(th) fluid among a plurality of thefluids present; and therefore, a third or more fluids can also exist asdescribed before.

In the production process of the organic material microparticle by usingthe microreactor (step 0 to step 2), the step 1 and the step (2) may becontinuously conducted by using the microreactor. Specifically, as shownin FIG. 2(B), besides the first introduction part d1 and the secondintroduction part d2, the third introduction part d3 is arranged in themicroreactor; and for example, the raw material solution of the organicmaterial microparticle is introduced as the first fluid from the firstintroduction part d1, the separating solvent of the organic materialmicroparticle is introduced as the second fluid from the secondintroduction part d2, and the particle property control solution isintroduced as the third fluid from the third introduction part d3; therespective fluids being separately introduced into the microreactor. Inthis case, the third introduction part d3 through which the particleproperty control solution is introduced is arranged in the downstreamside of the first introduction part d1 and the second introduction partd2; and to be more specific, by arranging the opening d30 of the thirdintroduction part d3 in the downstream side of the opening d20 of thesecond introduction part d2, the particle property control solution canact to the organic material microparticle separated between theprocessing surfaces 1 and 2. The microreactor provided with the threeopenings (d10, d20, and d30) is suitable when the step 1 and the step 2are continuously conducted.

However, in execution of the present invention, in the case that thestep 1 is conducted in the microreactor and the steps after the step 1are conducted outside the microreactor, at least two openings (d10 andd20) are enough, as shown in FIG. 1(A). However, in the case that thesurface treatment is conducted in the thin film fluid onto the organicmaterial microparticles separated between the processing surfaces 1 and2, though not limited to this case, it does not preclude to conduct thestep 1 by using the microreactor provided with three or more openings.

Especially when the above-mentioned microreactor is used, the organicmaterial of the present invention can be produced as the microparticle,wherein the particle diameter thereof can be made in the range of 1000nm or less, while preferably in the range of 500 nm or less, before andafter the treatment with the solvent which has a partial dissolvabilityto the organic material microparticle and the surfactant capable ofsuppressing the growth of the organic material microparticle. Inaddition, when the above-mentioned microreactor is used, control of thecrystallinity of the separated microparticle is comparatively easy; andthus, by separating the microparticle in the state of a lowcrystallinity containing the amorphous portion, the crystal type, thedegree of crystallinity, and the like of the microparticles in the step2 can be controlled more precisely. As the specific example of themicroreactor like this, ULREA (manufactured by M. Technique Co., Ltd.)may be mentioned. However, the method for producing the organic materialmicroparticle of the present invention is not limited to those using themicroreactor.

EXAMPLES

Hereinafter, the present invention will be explained more specificallyby means of Examples. However, the present invention is not limited tothe following Examples. In the following Examples, the A solution is thefirst fluid to be processed that is introduced from the firstintroduction part d1 of the apparatus shown in FIG. 2(A) and FIG. 2(B);and the B solution is the second fluid to be processed that isintroduced from the second introduction part d2 of the same apparatus.

In the present invention, all the Examples are separated into threegroups of Examples A. Examples B, and Examples C, and they are showntogether with respective Comparative Examples.

Examples A relate to the group of biologically ingestible substances andresins.

Examples B relate to the group of red organic pigments.

Examples C relate to the group of blue organic pigments.

Meanwhile, in the main body of the specification, the alphabetical groupsymbols of A, B, and C are tagged after respective Examples. However, inTables and drawings, the alphabetical group symbols A, B. and C areomitted.

Group of Examples A

As examples of the method for producing the organic materialmicroparticle of the present invention, explanation will be given bytaking the microparticles of indomethacin in Examples A1 to A4, curcuminin Examples A5 and A6, polypropylene in Example A7, and pirenoxine inExample A8, respectively.

In Examples A, for the X-ray diffraction measurement (XRD measurement),the powder X-ray diffraction measurement apparatus (product name: X'PertPRO MPD, manufactured by PANalytical B. V.) was used. The measurementconditions were as follows: measurement range of 10 to 600. Cuanticathode, tube voltage of 45 kV, tube current of 40 mA, and scanningspeed of 16°/min.

For the TEM observation, the transmission electron microscope JEM-2100(manufactured by JEOL Ltd.) was used. The observation condition with theacceleration voltage of 80 kV was employed.

For the SEM observation, the scanning electron microscope JFM-7500F(manufactured by JEOL Ltd.) was used. The observation condition with theacceleration voltage of 1 kV was employed.

Evaluation of the particle diameter was made with the average value of50 particles in the picture of the TEM observation or the SEMobservation with the magnification of 25000 in the both observations.

Meanwhile, the degree of crystallinity mentioned here is defined as theratio of the crystallized portion relative to the total of thecrystallized portion and the amorphous portion.

Example A1: Indomethacin Microparticle

<Step 0: Preparation of the separating solvent of the organic materialmicroparticle (A solution) and the raw material solution of the organicmaterial microparticle (B solution)>

Preparation of the Separating Solvent of the Organic MaterialMicroparticle (A Solution)

By using a magnetic stirrer, a 0.1 mol/L aqueous hydrochloric acidsolution was prepared as the separating solvent of indomethacin, theseparating solvent of the organic material microparticle (A solution).

Preparation of the Raw Material Solution of the Organic MaterialMicroparticle (B Solution)

Into a 0.35 mol/L aqueous sodium hydrogen carbonate solution were addedindomethacin (gamma-type crystal) and polyvinyl pyrrolidone (Kollidon 12PF; manufactured by BASF GmbH) so as to give the concentration of 0.2%by weight and 0.2% by weight, respectively, thereby the raw materialindomethacin solution was prepared as the raw material solution of theorganic material microparticle (B solution). The resulting mixture wasstirred by using Clearmix (product name: CLM-2.2S, manufactured by M.Technique Co., Ltd.), a high-speed rotation type dispersing emulsifier,with the rotor's rotation number of 15000 rpm and the temperature ofabout 35° C. for the period of 30 minutes so as to prepare the uniformraw material indomethacin solution. In such a case that pluralcomponents are mixed or dissolved, it is preferable to use Clearmix(product name: CLM-2.2S, manufactured by M. Technique Co., Ltd.) whichis a high-speed rotation type dispersing emulsifier.

<Step 1: Mixing and Separation>

Next, the prepared separating solvent of the organic materialmicroparticle and the prepared raw material solution of the organicmaterial microparticle were mixed by using the microreactor ULREA shownin FIG. 2(A). Specifically, from the first introduction part d1 of themicroreactor ULREA shown in FIG. 2(A), the prepared separating solventof the organic material microparticle (here, the 0.1 mol/L aqueoushydrochloric acid solution) was introduced as the first fluid to beprocessed (A solution) into between the processing surfaces with thesupply rate of 200 mL/min and the temperature of 5° C. With operatingthe processing member 10 with the rotation number of 1700 rpm, theprepared raw material indomethacin solution was introduced as the secondfluid to be processed (B solution) into between the processing surfaces1 and 2 with the supply rate of 30 mL/min and the temperature of 25° C.so as to mix them in a thin film fluid. Then, the solution containingthe indomethacin microparticles was discharged from the processingsurfaces 1 and 2.

<Step c: Recovery and Washing>

The above-mentioned discharged solution was filtrated to recover theindomethacin microparticles. Then, the indomethacin microparticles werewashed repeatedly with the washing solvent (pure water) to obtain a wetcake of the indomethacin microparticles. The wet cake was diluted withpure water, and this diluted solution was dropped onto a collodion filmand dried at room temperature to obtain the sample for observation, withwhich the TEM observation was conducted. The TEM observation result isshown in FIG. 4 . Separately, the wet cake was vacuum-dried at −0.095MPaG for 16 hours to obtain the dried powder. The X-ray diffractionmeasurement result of the obtained dry powder is shown in the uppercolumn of FIG. 5 .

From the TEM observation result, it was confirmed that the averageprimary particle diameter of the indomethacin microparticles was about76 nm. From the X-ray diffraction measurement result, it was confirmedthat the obtained particles were of amorphous.

<Step 2: Control of the Particle Properties>

In the step 2 for control of the particle properties, pure water wasused as the solvent which has a partial dissolvability to the organicmaterial microparticle, and hydroxyethyl cellulose (HEC) was used as thesurfactant capable of suppressing the growth of the organic materialmicroparticle. Pure water added with hydroxyethyl cellulose was stirredby using Clearmix Dissolver (product name: CLM-2.2S, manufactured by M.Technique Co., Ltd.), a high-speed rotation type dispersing emulsifier,with the rotor's rotation number of 15000 rpm for the period of 30minutes to obtain a uniformly mixed hydroxyethyl cellulose aqueoussolution (particle property control solution). The wet cake of theindomethacin microparticles obtained in the step c was introduced intothis particle property control solution, and then, the dispersiontreatment thereof was conducted.

Specifically, the indomethacin microparticles obtained in the step c wasadded into the aqueous solution containing 0.1% by weight ofhydroxyethyl cellulose (viscosity: 200 to 300 mPa·s, 2% in water at 20°C., manufactured by Tokyo Chemical Industry Co., Ltd. (TCI)) so as togive its concentration of 0.2% by weight. Then, the resulting mixturewas subjected to the dispersion treatment by using the ultrasonicdisperser (UP 200S; manufactured by Heilscher Ultrasonics GmbH) with0.5% output and 0.5 cycle for the period of 15 minutes and with thetreatment temperature of 37±3° C. to obtain the dispersion solution ofthe indomethacin microparticles. For the TEM observation, the obtaineddispersion solution of the indomethacin microparticles was dropped ontoa collodion film, and then, it was dried at room temperature to obtainthe sample for the observation. The TEM observation result thereof isshown in FIG. 6 .

From the TEM observation result, it was confirmed that the averageprimary particle diameter of the indomethacin microparticles afterhaving been acted by the aqueous solution containing 0.1% by weight ofhydroxyethyl cellulose was about 98 nm. Further, the indomethacinmicroparticles were recovered from the dispersion solution byfiltration; and after the microparticles were washed with pure water,they were vacuum-dried at −0.095 MPaG and the temperature of 25° C. for16 hours to obtain the dried powder. The X-ray diffraction measurementresult of the obtained dry powder is shown in the lower column of FIG. 5.

From the X-ray diffraction measurement result, it was confirmed that theindomethacin microparticles after having been acted by the 0.1% byweight hydroxyethyl cellulose aqueous solution in the step 2 underwentthe crystal transition to the alpha-type crystal. Meanwhile, forcomparison purpose, the X-ray diffraction measurement result of theindomethacin microparticles recovered and washed in the step c (beforethe treatment in the step 2) is also shown in FIG. 5 .

Example A2

The indomethacin microparticles were produced with the same condition asthat of Example A1 except that the concentration of hydroxyethylcellulose in the step 2 of Example A1 was changed from 0.1% by weight to0.05% by weight. The TEM picture of the indomethacin microparticlesobtained in the step 2 of Example A2 is shown in FIG. 7 . As can be seenin FIG. 7 , it was confirmed that the average primary particle diameterof the indomethacin microparticles was about 126 nm.

Comparative Example A1

As the solvent for control of the particle properties in the step 2 ofExample A1, only pure water which is the solvent having a partialdissolvability to indomethacin was used without being added with thesurfactant. Then, the indomethacin microparticles were produced with thesame conditions in the rest of the conditions as those of Example A1.

The TEM observation result of the indomethacin microparticles obtainedin the step 2 of Comparative Example A1 is shown in FIG. 8 . From theTEM observation result, it was confirmed that the particle was coarsenedto about 850 nm.

Example A3: Indomethacin Microparticle

The indomethacin microparticles were produced with the same conditionsfrom the step 0 to the step c as those of Example A1, though the solventwhich has a partial dissolvability to the organic material microparticlein the step 2 was changed from pure water in Example A1 to hexane, andthe surfactant capable of suppressing the growth of the organic materialmicroparticle was changed to Span 80 from hydroxyethyl cellulose inExample A1.

Specifically, the uniformly mixed hexane solution containing 0.01% byweight of Span 80 (manufactured by Wako Pure Chemical Industries, Ltd.)(particle property control solution) was prepared by stirring thissolution with Clearmix Dissolver (product name: CLM-2.2S, manufacturedby M. Technique Co., Ltd.), a high-speed rotation type dispersingemulsifier, with the rotor's rotation number of 15000 rpm for the periodof 30 minutes. After the indomethacin microparticles obtained in thestep c was added to the particle property control solution so as to giveits concentration of 0.2% by weight, the resulting mixture was subjectedto the dispersion treatment by stirring by means of a magnetic stirrerat 150 rpm and the temperature of 27° C. for 16 hours to obtain thedispersion solution of the indomethacin microparticles. From thedispersion solution thereby obtained, the indomethacin microparticleswere recovered by filtration, and then vacuum-dried at −0.095 MPaG andthe temperature of 25° C. for 16 hours to obtain the dried powder forthe X-ray diffraction measurement. The X-ray diffraction measurementresult thereof is shown in the lower column of FIG. 9 . Meanwhile, inthe upper column of FIG. 9 , the X-ray diffraction measurement result ofthe indomethacin microparticles obtained in the step c of Example A3 isshown.

From the X-ray diffraction measurement result, it was confirmed that theindomethacin microparticles after having been acted by the hexanesolution containing 0.01% by weight of Span 80 was transformed to thegamma-type crystal.

Thereafter, the dried powder was dispersed into the aqueous solutioncontaining 0.1% by weight of hydroxyethyl cellulose (viscosity: 200 to300 mPa·s, 2% in water at 20° C., manufactured by Tokyo ChemicalIndustry Co., Ltd. (TCI)) to obtain the sample for the TEM observation.The TEM observation result thereof is shown in FIG. 10 .

From the TEM observation result, it was confirmed that the averageprimary particle diameter of the indomethacin microparticles afterhaving been acted by the hexane solution containing 0.01% by weight ofSpan 80 (particle property control solution) in the step 2 of Example A3was about 138 nm.

Comparative Example A2: Indomethacin Microparticle

As the solvent for control of the particle properties in the step 2 ofExample A3, only hexane which is the solvent having a partialdissolvability to indomethacin was used without being added with thesurfactant. Then, the indomethacin microparticles were produced with thesame conditions in the rest of the conditions as those of Example A3.

The TEM observation result of the indomethacin microparticles obtainedin the step 2 of Comparative Example A2 is shown in FIG. 11 . From theTEM observation result, it was confirmed that the particles werecoarsened to about 1000 nm.

Example A4: Indomethacin Microparticle

In Example A4, the separating solvent of indomethacin and the rawmaterial indomethacin solution in the step 0 of Examples A1 to A3 werechanged; then the alpha-type indomethacin microparticle was separated inthe step 1. In addition, the surfactant capable of suppressing thegrowth of the organic material microparticle in the step 2 of Example A1was changed.

In the step 0, pure water was used as the separating solvent of theorganic microparticle (A solution). This solvent was not preparedbecause only pure water was used for it. Into ethanol were addedindomethacin having the gamma-type crystal and polyvinyl pyrrolidone(Kollidon 12 PF; manufactured by BASF GmbH) so as to give theconcentration of 1.0% by weight and 1.0% by weight, respectively,thereby the raw material indomethacin solution was prepared as the rawmaterial solution of the organic material microparticle (B solution).Similarly to Examples A1 to A3, the resulting mixture was stirred byusing Clearmix (product name: CLM-2.2S, manufactured by M. TechniqueCo., Ltd.), a high-speed rotation type dispersing emulsifier, with therotor's rotation number of 15000 rpm and the temperature of about 35° C.for the period of 30 minutes so as to prepare the uniform raw materialindomethacin solution.

Procedures of the step 1 (mixing and separation) and the step c(recovery and washing) were the same as Examples A1 to A3. Similarly toExamples A1 to A3, the indomethacin microparticles were separated in thestep 1; and by using the wet cake obtained in the step c, the sample forthe TEM observation and the dried powder for the X-ray diffractionmeasurement were obtained. The TEM observation result is shown in FIG.12 , and the X-ray diffraction measurement result is shown in the uppercolumn of FIG. 13 .

From the TEM observation result, it was confirmed that the averageprimary particle diameter of the indomethacin microparticles afterhaving been subjected to the washing treatment was about 146 nm. Fromthe X-ray diffraction measurement result, it was confirmed that thecrystal type of the indomethacin microparticles was the alpha-type.Meanwhile, the degree of crystallinity thereof was 50%.

<Step 2: Control of the Particle Properties>

In the step 2 for control of the particle properties, pure water wasused as the solvent which has a partial dissolvability to the organicmaterial microparticle, and Lutrol F127 (manufactured by BASF GmbH) wasused as the surfactant capable of suppressing the growth of the organicmaterial microparticle. Pure water added with Lutrol F127 was stirred byusing Clearmix Dissolver (product name: CLM-2.2S, manufactured by M.Technique Co., Ltd.), a high-speed rotation type dispersing emulsifier,with the rotor's rotation number of 15000 rpm for the period of 30minutes to obtain a uniformly mixed Lutrol F127 aqueous solution(particle property control solution). The wet cake of the indomethacinmicroparticles obtained in the step c was introduced into this particleproperty control solution, and then, the dispersion treatment thereofwas conducted.

Specifically, the indomethacin microparticles obtained in the step c wasadded into the aqueous solution containing 0.1% by weight of Lutrol F127so as to give its concentration of 0.2% by weight. Then, the resultingmixture was subjected to the dispersion treatment by using theultrasonic disperser (UP 200S; manufactured by Heilscher UltrasonicsGmbH) with 0.5% output and 0.5 cycle for the period of 15 minutes andwith the treatment temperature of 37±3° C. to obtain the indomethacindispersion solution. The obtained indomethacin dispersion solution wasdropped onto a collodion film, and then, it was dried at roomtemperature to obtain the sample for the TEM observation. The TEMobservation result thereof is shown in FIG. 14 .

From the TEM observation result, it was confirmed that the averageprimary particle diameter of the indomethacin microparticles afterhaving been acted by the aqueous solution containing 0.1% by weight ofLutrol F127 was about 168 nm. Further, the indomethacin microparticleswere recovered from the dispersion solution by filtration, and after themicroparticles were washed with pure water, they were vacuum-dried at−0.095 MPaG and with the temperature of 25° C. for 16 hours to obtainthe dried powder for the X-ray diffraction measurement. The X-raydiffraction measurement result thereof is shown in the lower column ofFIG. 13 .

From the X-ray diffraction measurement result, it was confirmed that theindomethacin microparticle after having been acted by the aqueoussolution containing 0.1% by weight of Lutrol F127 was of the alpha-typecrystal, the same as the indomethacin microparticle obtained in the stepc. The degree of crystallinity thereof was 62.5%; and thus, it wasconfirmed that the degree of crystallinity was increased as comparedwith the indomethacin microparticle obtained in the step c. This ispresumably because the amorphous portion contained in the indomethacinmicroparticles obtained in the step 1 and step 2 was crystallized.

Comparative Example A3: Indomethacin Microparticle

As the solvent for control of the particle properties in the step 2 ofExample A4, only pure water which is the solvent having a partialdissolvability to indomethacin was used without being added with thesurfactant. Then, the indomethacin microparticles were produced with thesame conditions in the rest of the conditions as those of Example A4.

The TEM observation result thereof is shown in FIG. 15 . From the TEMobservation result, it was confirmed that the particles were coarsenedto about 1160 nm.

Example A5: Curcumin Microparticle <Step 0: Preparation of theSeparating Solvent of the Organic Material Microparticle (a Solution)and the Raw Material Solution of the Organic Material Microparticle (BSolution)>

In the step 0, pure water was used as the separating solvent of theorganic microparticle (A solution). This solvent was not preparedbecause only pure water was used for it. Into ethanol were addedcurcumin having the 1-type crystal and polyvinyl pyrrolidone (Kollidon12 PF; manufactured by BASF GmbH) so as to give the concentrations of0.5% by weight and 0.5% by weight, respectively, thereby the rawmaterial curcumin solution was prepared as the raw material solution ofthe organic material microparticle (B solution). Similarly to ExamplesA1 to A4, the resulting mixture was stirred by using Clearmix (productname: CLM-2.2S, manufactured by M. Technique Co., Ltd.), a high-speedrotation type dispersing emulsifier, with the rotor's rotation number of15000 rpm and the temperature of about 35° C. for the period of 30minutes so as to prepare the uniform raw material curcumin solution.

<Step 1: Mixing and Separation>

Next, the separating solvent of the organic material microparticle andthe prepared raw material solution of the organic material microparticlewere mixed by using the microreactor shown in FIG. 2(A). Specifically,from the first introduction part d1 of the microreactor shown in FIG.2(A), the separating solvent of the organic material microparticle(here, pure water) was introduced as the first fluid to be processed (Asolution) into between the processing surfaces with the supply rate of500 mL/min and the temperature of 5° C.; and with operating theprocessing member 10 at the rotation number of 1700 rpm, the preparedraw material solution of the organic material microparticle wasintroduced as the second fluid to be processed (B solution) into betweenthe processing surfaces 1 and 2 with the supply rate of 30 mL/min andthe temperature of 25° C. so as to mix them in a thin film fluid. Then,the solution containing the curcumin microparticles was discharged fromthe processing surfaces 1 and 2.

<Step c: Recovery and Washing>

The above-mentioned discharged solution was filtrated to remove thesupernatant liquid so as recover the curcumin microparticles. Then, thecurcumin microparticles were repeatedly washed for three times with thewashing solvent (pure water) to obtain a wet cake of the curcuminmicroparticles. This wet cake was diluted with pure water, and theresulting diluted solution was dropped onto a collodion film and driedat room temperature to obtain the sample for observation, with which theTEM observation was conducted.

Separately, the foregoing wet cake was vacuum-dried at −0.095 MPaG for16 hours to obtain the dried powder for the X-ray measurement. The TEMobservation result is shown in FIG. 16 , and the X-ray diffractionmeasurement result is shown in the upper column of FIG. 17 .

From the TEM observation result, it was confirmed that the averageprimary particle diameter of the curcumin microparticles was about 88nm. From the X-ray diffraction measurement result, it was confirmed thatthe obtained particles were of amorphous.

<Step 2: Control of the Particle Properties>

In the step 2 for control of the particle properties, pure water wasused as the solvent which has a partial dissolvability to the organicmaterial microparticle, and polyvinyl alcohol was used as the surfactantcapable of suppressing the growth of the organic material microparticle.Pure water added with polyvinyl alcohol (PVA) was stirred by usingClearmix Dissolver (product name: CLM-2.2SD, manufactured by M.Technique Co., Ltd.), a high-speed rotation type dispersing emulsifier,with the rotor's rotation number of 15000 rpm for the period of 30minutes to obtain a uniformly mixed polyvinyl alcohol aqueous solution(particle property control solution). The wet cake of the curcuminmicroparticles obtained in the step c was introduced into this particleproperty control solution, and then, the dispersion treatment thereofwas conducted.

Specifically, the curcumin microparticles obtained in the step c wasadded into the aqueous solution containing 0.2% by weight of polyvinylalcohol 500 (completely saponified type) so as to give its concentrationof 0.2% by weight. Then, the resulting mixture was subjected to thedispersion treatment by using the ultrasonic disperser (UP 200S:manufactured by Heilscher Ultrasonics GmbH) with 0.5% output and 0.5cycle and with the treatment temperature of 30±3° C. for the period of30 minutes to obtain the dispersion solution of the curcuminmicroparticles. The obtained dispersion solution was dropped onto acollodion film, and then, it was dried at room temperature to obtain thesample for the TEM observation. The TEM observation result thereof isshown in FIG. 18 .

From the TEM observation result, it was confirmed that the averageprimary particle diameter of the curcumin microparticles after havingbeen acted by the aqueous solution containing 0.2% by weight ofpolyvinyl alcohol 500 (completely saponified type) was about 108 nm.Further, the curcumin microparticles were recovered from the dispersionsolution by filtration; and after the microparticles were washed withpure water, they were vacuum-dried at −0.095 MPaG with the temperatureof 25° C. for 12 hours to obtain the dried powder for the X-raydiffraction measurement. The X-ray diffraction measurement resultthereof is shown in the middle column of FIG. 17 .

From the X-ray diffraction measurement result, it was confirmed that thecurcumin microparticle after having been acted by the aqueous solutioncontaining 0.2% by weight of polyvinyl alcohol 500 (completelysaponified type) was transformed from amorphous to the 3-type crystal.

Comparative Example A4

As the solvent for control of the particle properties in the step 2 ofExample A5, only pure water which is the solvent having a partialdissolvability to curcumin was used without being added with thesurfactant. Then, the curcumin microparticles were produced with thesame conditions in the rest of the conditions as those of Example A5.

The TEM observation result thereof is shown in FIG. 19 . From the TEMobservation result, it was confirmed that, although the crystal wastransformed to the 3-type crystal, the average particle diameter of thecurcumin microparticles was about 980 nm, thereby showing that theparticles thereof were coarsened.

Example A6

The curcumin microparticles were produced with the same conditions fromthe step 0 to the step c as those of Example A5, though the solventwhich has a partial dissolvability to the organic material microparticlein the step 2 was changed from pure water in Example A5 to hexane.

Span 80 (manufactured by Wako Pure Chemical Industries, Ltd.) was usedas the surfactant capable of suppressing the growth of the organicmaterial microparticle. Hexane added with Span 80 was stirred by usingClearmix Dissolver (product name: CLM-2.2SD, manufactured by M.Technique Co., Ltd.), a high-speed rotation type dispersing emulsifier,with the rotor's rotation number of 15000 rpm for the period of 30minutes to obtain a uniformly mixed solution (particle property controlsolution). The dried powder of the curcumin microparticles obtained inthe step c was introduced into this particle property control solution,and then, the dispersion treatment thereof was conducted.

Specifically, the curcumin microparticles obtained in the step c wereadded into the hexane solution containing 0.01% by weight of Span 80 soas to give its concentration of 0.2% by weight. Then, the resultingmixture was subjected to the dispersion treatment with the samecondition as that of Example A5 to obtain the curcumin microparticles.From the obtained dispersion solution, the curcumin microparticles wererecovered by filtration, which was followed by vacuum-drying at −0.095MPaG with the temperature of 25° C. for 16 hours to obtain the driedpowder for the X-ray diffraction measurement. The X-ray diffractionmeasurement result thereof is shown in the lower column of FIG. 17 .

From the X-ray diffraction measurement result, it was confirmed that thecurcumin microparticle after having been acted by the hexane solutioncontaining 0.1% by weight of Span 80 was transformed from amorphous tothe 2-type crystal.

Thereafter, the dried powder was dispersed into the aqueous solutioncontaining 0.1% by weight of hydroxyethyl cellulose (viscosity: 200 to30) mPa·s, 2% in water at 20° C., manufactured by Tokyo ChemicalIndustry Co., Ltd. (TCI)) to obtain the sample for the TEM observation.The TEM observation result thereof is shown in FIG. 20 . From the TEMobservation result, it was confirmed that the average primary particlediameter of the curcumin microparticles after having been acted by thehexane solution containing 0.1% by weight of Span 80 was about 97 nm.

Comparative Example A5

As the solvent for control of the particle properties in the step 2 ofExample A6, only hexane which is the solvent having a partialdissolvability to curcumin was used without being added with thesurfactant. Then, the curcumin microparticles were produced with thesame conditions in the rest of the conditions as those of Example A6.

The TEM observation result of the curcumin microparticles obtained inthe step 2 of Comparative Example A5 is shown in FIG. 21 . From the TEMobservation result, it was confirmed that, although the crystal thereofwas transformed to the 3-type crystal, the particles were coarsened to1000 nm or more.

Example A7: Polypropylene Microparticle <Step 0: Preparation of theSeparating Solvent of the Organic Material Microparticle (A Solution)and the Raw Material Solution of the Organic Material Microparticle (BSolution)>

In the step 0, acetone was used as the separating solvent of the organicmicroparticle (A solution). This solvent was not prepared because onlyacetone was used for it. Polypropylene having the alpha-type crystal wasadded into toluene so as to give the raw material polypropylene solutionwith the concentration of 1% by weight as the raw material solution ofthe organic material microparticle (B solution). Similarly to ExamplesA1 to A6, the resulting mixture was stirred by using Clearmix (productname: CLM-2.2S, manufactured by M. Technique Co., Ltd.), a high-speedrotation type dispersing emulsifier, with the rotor's rotation number of15000 rpm and the temperature of about 85° C. for the period of 30minutes so as to prepare the uniform raw material polypropylenesolution.

<Step 1: Mixing and Separation>

In Example A7, as the step 1 of a batch method in Example A, theseparating solvent of the organic material microparticle and the rawmaterial solution of the organic material microparticle were mixed byusing Clearmix. Specifically, 30 mL of the prepared raw materialsolution of the organic material microparticle (B solution) with thetemperature of 80° C. was slowly dropped into 500 mL of acetone (Asolution) cooled to 5° C. with stirring the acetone solution at 15000rpm. Then, the solution containing the polypropylene microparticles wasrecovered from Clearmix.

<Step c: Recovery and Washing>

The above-mentioned solution containing the polypropylene microparticleswas filtrated to remove the supernatant so as to recover thepolypropylene microparticles. After having been repeatedly washed withthe washing solvent (acetone), a wet cake of the polypropylenemicroparticles was obtained.

The wet cake thus obtained was vacuum-dried at −0.095 MPaG for 16 hoursto obtain the dried powder for the SEM observation and for the X-raydiffraction measurement. The SEM observation result is shown in FIG. 22, and the X-ray diffraction measurement result is shown in the uppercolumn of FIG. 23 .

From the SEM observation result, it was confirmed that the averageprimary particle diameter of the polypropylene microparticles was about124 nm. From the X-ray diffraction measurement result, it was confirmedthat the particles thus obtained were of the alpha-type crystal.Meanwhile, the degree of crystallinity thereof was 85.6%.

<Step 2: Control of the Particle Properties>

In the step 2 for control of the particle properties, an aqueousisopropanol solution (IPA+pure water) was used as the solvent which hasa partial dissolvability to the organic material microparticle, andTween 80 (manufactured by Wako Pure Chemical Industries, Ltd.) was usedas the surfactant capable of suppressing the growth of the organicmaterial microparticle. The aqueous isopropanol solution added withTween 80 was stirred by using Clearmix Dissolver (product name:CLM-2.2SD, manufactured by M. Technique Co., Ltd.), a high-speedrotation type dispersing emulsifier, with the rotor's rotation number of15000 rpm for the period of 30 minutes to obtain a uniformly mixedaqueous solution (particle property control solution). The wet cake ofthe polypropylene microparticles obtained in the step c was introducedinto this particle property control solution, and then, the dispersiontreatment thereof was conducted.

Specifically, the polypropylene microparticles obtained in the step cwas added into the aqueous solution comprising 0.1% by weight of Tween80, 2.0% by weight of isopropyl alcohol, and 97.9% by weight of water soas to give the concentration of the polypropylene microparticles of 0.2%by weight. Then, the resulting mixture was subjected to the dispersiontreatment by using the ultrasonic disperser (UP 200S; manufactured byHeilscher Ultrasonics GmbH) with 0.5% output and 0.5 cycle and with thetreatment temperature of 70±3° C. for the period of 15 minutes to obtainthe dispersion solution of the polypropylene microparticles. From theobtained dispersion solution, the polypropylene microparticles wererecovered by filtration, which was followed by vacuum-drying at −0.095MPaG and with the temperature of 25° C. for 16 hours to obtain the driedpowder for the SEM observation and for the X-ray diffractionmeasurement. The SEM observation result is shown in FIG. 24 , and theX-ray diffraction measurement result is shown in the lower column ofFIG. 23 .

From the SEM observation result, it was confirmed that the averageprimary particle diameter of the polypropylene microparticles was about197 nm. From the X-ray diffraction measurement result, it was confirmedthat the crystal type of the obtained particle was of the alpha-type,the same as that of the polypropylene microparticle obtained in the stepc. Meanwhile, the degree of crystallinity thereof was 93.5%; and thus,it was confirmed that the degree of crystallinity was higher than thatof the polypropylene microparticle obtained in the step c. This ispresumably because the amorphous portion contained in the polypropylenemicroparticles obtained in the steps 1 and 2 was crystallized.

Comparative Example A6

As the solvent for control of the particle properties in the step 2 ofExample A7, only an isopropanol aqueous solution (2.0% by weightisopropyl alcohol/98.0% by weight water) was used as the solvent havinga partial dissolvability to polypropylene without adding the surfactant.Then, the polypropylene microparticles were produced with the sameconditions in the rest of the conditions as those of Example A7.

The SEM observation result thereof is shown in FIG. 25 . From the SEMobservation result, it was confirmed that the average primary particlediameter thereof was about 512 nm.

Example A8: Pirenoxine Microparticle <Step 0: Preparation of theSeparating Solvent of the Organic Material Microparticle (A Solution)and the Raw Material Solution of the Organic Material Microparticle (BSolution)> Preparation of the Separating Solvent of the Organic MaterialMicroparticle (A Solution)

The separating solvent of pirenoxine as the separating solvent of theorganic material microparticle (A solution) was prepared by mixingcitric acid with pure water so as to give its concentration of 1.9% byweight. The resulting mixture was stirred by using Clearmix (productname: CLM-2.2S, manufactured by M. Technique Co., Ltd.), a high-speedrotation type dispersing emulsifier, with the rotor's rotation number of15000 rpm and the temperature of about 35° C. for the period of 30minutes so as to prepare the uniform pirenoxine separating solvent. ThepH of the pirenoxine separating solvent thus prepared was 2.1

Preparation of the Raw Material Solution of the Organic MaterialMicroparticle (B Solution)

Pirenoxine was added into a 0.01 mol/L aqueous sodium hydroxide solutionso as to give its concentration of 0.2% by weight, thereby the rawmaterial pirenoxine solution was prepared as the raw material solutionof the organic material microparticle (B solution). The resultingmixture was stirred by using Clearmix (product name: CLM-2.2S,manufactured by M. Technique Co., Ltd.), a high-speed rotation typedispersing emulsifier, with the rotor's rotation number of 15000 rpm andthe temperature of about 35° C. for the period of 30 minutes so as toprepare the uniform raw material pirenoxine solution. The pH of the rawmaterial pirenoxine solution thus prepared was 12.0.

<Step 1: Mixing and Separation>

Next, the prepared separating solvent of the organic materialmicroparticle and the prepared raw material solution of the organicmaterial microparticle were mixed by using the microreactor shown inFIG. 2(A). Specifically, from the first introduction part d1 of themicroreactor shown in FIG. 2(A), the prepared pirenoxine separatingsolvent (here, 1.9% by weight of aqueous citric acid solution) wasintroduced as the first fluid to be processed (A solution) into betweenthe processing surfaces with the supply rate of 300 mL/min and thetemperature of 25° C.; and with operating the processing member 10 atthe rotation number of 1700 rpm, the prepared raw material pirenoxinesolution was introduced as the second fluid to be processed (B solution)into between the processing surfaces 1 and 2 with the supply rate of 20mL/min and the temperature of 25° C. so as to mix them in a thin filmfluid. Then, the solution containing the pirenoxine microparticles wasdischarged from the processing surfaces 1 and 2. The pH of thedischarged solution containing the pirenoxine microparticles was 2.48.

The discharged solution containing the pirenoxine microparticles wasdropped onto a collodion film and dried at room temperature to obtainthe sample for observation, with which the TEM observation wasconducted. From the TEM observation result, it was confirmed that theaverage primary particle diameter of the pirenoxine microparticles wasabout 42 nm. The TEM observation result is shown in FIG. 26 .

<Step 2: Control of the Particle Properties>

In the step 2 for control of the particle properties, pure water wasused as the solvent which has a partial dissolvability to the organicmaterial microparticle, and Tween 80 and benzalkonium chloride were usedas the surfactants capable of suppressing the growth of the organicmaterial microparticle. Pure water added with Tween 80 and benzalkoniumchloride was stirred by using Clearmix Dissolver (product name.CLM-2.2SD, manufactured by M. Technique Co., Ltd.), a high-speedrotation type dispersing emulsifier, with the rotor's rotation number of15000 rpm for the period of 15 minutes to obtain a uniformly mixedaqueous solution of Tween 80 and benzalkonium chloride (particleproperty control solution). The dispersion solution of the pirenoxinemicroparticles obtained in the step 1 was introduced into this particleproperty control solution, and then, the dispersion treatment thereofwas conducted.

Specifically, 500 g of the dispersion solution of the pirenoxinemicroparticles obtained in the step 1 was added into 500 g of themixture solution comprising 0.03% by weight of Tween 80, 0.01% by weightof benzalkonium chloride, and 99.96% by weight of pure water. Then, theresulting mixture was subjected to the dispersion treatment by usingClearmix Double Motion (CLM-2.2/3.7W; manufactured by M. Technique Co.,Ltd.) with the rotor's rotation number of 20000 rpm and the screen'srotation number of 18000 rpm and with the treatment temperature of 42±3°C. for the period of 30 minutes to obtain the dispersion solution of thepirenoxine microparticles. For the TEM observation, the obtaineddispersion solution of the pirenoxine microparticles was dropped onto acollodion film, and then, it was dried at room temperature to obtain thesample for the observation. The TEM observation result thereof is shownin FIG. 27 .

From the TEM observation result, it was confirmed that the averageprimary particle diameter of the pirenoxine microparticles after havingbeen subjected to the treatment with the aqueous solution containingTween 80 was about 48 nm. Further, the pirenoxine microparticles wererecovered from the dispersion solution by filtration; and after themicroparticles were washed with pure water, they were vacuum-dried at−0.095 MPaG with the temperature of 25° C. for 16 hours to obtain thedried powder. The X-ray diffraction measurement result of the obtaineddry powder is shown in the lower column of FIG. 28 . Meanwhile, for acomparison purpose, the dispersion solution of the pirenoxinemicroparticles before being subjected to the dispersion treatment in thestep 2 (discharged solution of the step 1) was recovered by filtrationin the same way as before; and after the pirenoxine microparticles werewashed with pure water, they were dried with the same condition asbefore. Then, the XRD diffraction measurement of the dry powder thusobtained was conducted. The result thereof is shown in the upper columnof FIG. 28 . From the XRD diffraction measurement result, it wasconfirmed that the degree of crystallinity after the dispersiontreatment in the step 2 was 63.2%, which was increased from 58.1% as thedegree of crystallinity, the value before the dispersion treatment inthe step 2. In addition, from the XRD diffraction measurement thereof,it was confirmed that there was no change in the crystal type of theobtained particles before and after the treatment.

The results of Example A1 to A8 and Comparative Examples A1 to A6 aresummarized in Table 1.

TABLE 1 After step c (after step 1 only in Example 8) Aster step 2 Xb:Xa: Rate of Xa/Xb: Average Average change in Rate of primary Degreeprimary Degree average change in particle of particle of primary degreeof Organic diameter crystal- Crystal Step 2 diameter crystal- Crystalparticle crystal- microparticle (nm) linity type Solvent Surfactant (nm)linity type diameter linity Example 1 Indomethacin 76 — — Pure water HEC98 42.45 α 1.29 Crystallized Example 2 Indomethacin 76 — — Pure waterHEC 126 38.18 α 1.66 Crystallized Comparative Indomethacin 76 — — Purewater None 850 45.50 α 11.18 Crystallized Example 1 Example 3Indomethacin 76 — — Hexane Span 80 138 39.76 γ 1.82 CrystallizedComparative Indomethacin 76 — — Hexane None 1000 45.04 γ 13.16Crystallized Example 2 Example 4 Indomethacin 146 50.0 α Pure waterLutrol F127 168 62.5 α 1.15 1.25 Comparative Indomethacin 146 50.0 αPure water None 1160 65.0 α 7.95 1.30 Example 3 Example 5 Curcumin 88 —— Pure water PVA 500 108 39.36 3 1.23 Crystallized (completelysaponified) Comparative Curcumin 88 — — Pure water None 980 35.64 311.14 Crystallized Example 4 Example 6 Curcumin 88 — — Hexane Span 80 9736.65 2 1.10 Crystallized Comparative Curcumin 88 — — Hexane None 100035.94 3 11.36 Crystallized Example 5 Example 7 Polypropylene 124 85.6 αIPA + Tween 80 197 93.5 α 1.59 1.09 Pure water Comparative Polypropylene124 85.6 α IPA + None 512 91.2 α 4.12 1.07 Example 6 Pure water Example8 Pirenoxine 42 58.1 x Pure water Tween 80 + 48 63.2 x 1.14 1.08benzalkonium chloride

Meanwhile, the symbol “—” shown in the column of “Degree ofcrystallinity” in Table 1 indicates that the crystallinity is amorphous.The degree of crystallinity is measured with XRD as mentioned before;and the rate of change in the degree of crystallinity is defined as therate (Xa/Xb), that is, with regard to before and after the treatmentwith the particle property control solution of the organic materialmicroparticle in the step 2, the value (Xa) of the average primaryparticle diameter after the treatment in the step 2 relative to thevalue (Xb) of the average primary particle diameter before the treatmentin the step 2, namely after completion of the treatment in the step c(after the treatment in the step 1 only in Example A8). With regard topirenoxine, because generally the name of crystal type is not used, thecolumn of the crystal type of Example A8 in Table 1 is shown by thesymbol “x”, with which it is indicated that there was no change in thecrystal type before and after the treatment of the step 2.

From the results of Examples A1 and A2 and Comparative Example A1, itcan be seen that in pure water, the solvent which has a partialdissolvability to indomethacin, the indomethacin microparticle becomescoarse, but when the particle property control is conducted in the step2 in which the surfactant capable of suppressing the growth of theorganic material microparticle is added to the said solvent, theparticle diameter of the indomethacin microparticle does notsubstantially change, thereby the coarsening of the particle can besuppressed. In addition, it can be seen that when the particle propertycontrol of the step 2 is conducted, the crystal transition from theamorphous to the alpha-type can take place.

In addition, from the results of Examples A1 and A2 and Example A3, itwas confirmed that even if the solvent which has a partialdissolvability to indomethacin and the surfactant capable of suppressingthe growth of indomethacin are changed, the effects of the particleproperty control of the step 2 can be obtained.

From the results of Examples A1 to A4, it can be seen that the effectsof the particle property control in the step 2 is not dependent on thecrystal type of indomethacin. Further, it can be seen that when theparticle property control of the step 2 was conducted, not only thecrystal transition took place but also the degree of crystallinityincreased.

As shown in Examples A5 to A8 and Comparative Examples A4 to A6, it isshown that the above-mentioned effects can be expressed not only inindomethacin in Examples A1 to A4 but also in other organic materialmicroparticles.

Further, from the result of Example A8, it was confirmed that even ifthe step c in which washing and/or solvent substitution is conducted tothe organic material microparticle obtained in the step 1 is omitted,the effects of the particle property control of the step 2 can beobtained.

Group of Examples B

Hereunder, the group of Examples B (red organic pigments) will beexplained.

For the XRD measurement of Examples B, the powder X-ray diffractionmeasurement apparatus (product name: X'Pert PRO MPD, manufactured byPANalytical B. V.) was used. The measurement conditions were as follows:measurement range of 6 to 60°, Cu anticathode, tube voltage of 45 kV,tube current of 40 mA, and scanning speed of 16°/min.

For the TEM observation, the transmission electron microscope JEM-2100(manufactured by JEOL Ltd.) was used. The observation conditions withthe acceleration voltage of 80 kV and the observation magnification of25000 were employed.

(Case of the Batch Method)

Similarly to Examples A, the pigment microparticles were producedaccording to the step 0 to step 2 as illustrated in FIG. 1 .

(Step 0)

Preparation of the separating solvent of the pigment microparticle (Asolution) and the raw material solution of the pigment microparticle (Bsolution) shown in Table 2 below: both the A and B solutions wereprepared by stirring the respective solutions by means of a magneticstirrer and a stirring bar at the rotation number of 300 rpm for theperiod of 30 minutes with the temperature of 40° C.

(Step 1)

Mixing of the A and B solutions: as shown in Table 2 below, the Bsolution was introduced into the A solution with stirring the A solutionby means of a magnetic stirrer and a stirring bar at the rotation numberof 300 rpm, resulting in separation of the organic pigmentmicroparticles. Meanwhile, after the slurry containing the organicpigment microparticles obtained in the step 1 were filtrated, theorganic pigment microparticles were washed with pure water (step c),thereby a wet cake of the organic pigment microparticles was obtained.Alternatively, by conducting the drying treatment of the organic pigmentmicroparticles with the method such as a vacuum-drying method, the driedpowder thereof was obtained.

(Step 2)

The wet cake or the dry powder of the organic pigment microparticlesmentioned above was introduced into a solvent having a partialdissolvability to the organic material microparticle (particle propertycontrol solution) and having a surfactant or a dispersant added therein.The resulting mixture was subjected to the stirring treatment for aprescribed time by using the Clearmix CLM-2.2S stirrer equipped with arotating and stirring blade.

TABLE 2 Temperature Amount of Temperature Charge rate Charge time of Bsolution Experiment A solution of A solution of B solution of B solutionintroduced No. A solution (mL) (° C.) B solution (mL/min) (min) (° C.)a-1 to a-11 20 wt % 500 5.2 DMSO/40 50 1 40.2 acetic wt % BTMA acid/pureMeOH water soln/PR 254 63/28/9 (weight ratio) b-1 to b-3  20 wt % 8005.3 DMSO/40 30 1 40.6 acetic wt % BTMA acid/pure MeOH water soln/PR 12263/28/9 (weight ratio)

The abbreviations used are as follows: DMSO: dimethyl sulfoxide, BTMA:benzyl trimethyl ammonium hydroxide, MeOH: methanol, soln: solution, PR254: C. I. Pigment Red 254, PR 122: C. I. Pigment Red 122.

After washing in the step c, with regard to each of the pigmentmicroparticles after stirring in the step 2, the average primaryparticle diameter was calculated with the TEM observation, and thedegree of crystallinity was measured with the XRD measurement; and theywere compared to each other (see, Table 3 shown below). Here, the degreeof crystallinity is defined as the ratio of the crystallized portionrelative to the total of the crystallized portion and the amorphousportion, wherein when the degree of crystallinity of the pigment ishigher, durability to light, heat, humidity, or the like becomes higher.Meanwhile, definitions of the symbols ⊚, ◯, Δ, and X are as follows.

When Da is defined as the average primary particle diameter of theparticles after the action of the step 2, and db is defined as theaverage primary particle diameter before the step 2 and after thewashing, the symbol ⊚ is defined as follows:

Da/db is in the range of 1.0 and 4.0, and

when Xa designates the degree of crystallinity of the particles afterthe action of the step 2 and Xb designates the degree of crystallinitybefore the step 2 and after the washing,

Xa/Xb is in the range of 1.05 or more, and

Da is in the range of 80 nm or less, and

in view of uniformity of the microparticles, at the time of TEMobservation of three view fields with 25000 magnification, the particleshaving the size of more than 8.0 times relative to db are not found atall among the individual pigment microparticles after the step 2 (afterthe action).

The symbol ◯ is defined as follows:

Da/db is in the range of 1.0 and 4.0, and

Xa/Xb is in the range of 1.05 or more, and

Da is in the range of more than 80 nm, and

in view of uniformity of the microparticles, at the time of TEMobservation of three view fields with 25000 magnification, the particleshaving the size of more than 8.0 times relative to db are not found atall among the individual pigment microparticles after the step 2 (afterthe action).

The symbol A is defined as follows:

Da/db is in the range of 1.0 and 4.0, and

Xa/Xb is in the range of 1.05 or more, and

in view of uniformity of the microparticles, at the time of TEMobservation of three view fields with 25000 magnification, a maximum ofone particle having the size of more than 8.0 times relative to db isfound among the individual pigment microparticles after the step 2(after the action).

The symbol X is defined when any of ⊚, ◯, Δ is not applicable.

Meanwhile, the average particle diameter was obtained with themeasurement of total 100 microparticles observed in plural view fieldsat the time of TEM observation with 25000 magnifications.

TABLE 3 Step 2 Stirring Step c washing Ratio of Average surfactant/Average Step c→ 2 Step c→ 2 primary dispersant primary Change in ChangeExample/ Exper- Separa- particle to pigment particle particle indegreeof Compar- iment tion diameter Crystal Surfactant/ (% by diameterCrystal diameter crystallinity Judge- ative No. method (nm) type Solventdispersant weight) (nm) type [Da/Db] [Xa/Xb] ment Example a-1 Batch124.1 β PGMEA — — 999.6 α 8.05 1.97 X C. Example a-2 Batch 124.1 β PGMEABYK-2000 100 197.8 α 1.59 2.31 ◯ Example a-3 Batch 124.1 β PGMEA BYK-108100 213.4 α 1.72 2.16 ◯ Example a-4 Batch 124.1 β PGMEA Pelex TR 100312.1 α 2.51 3.16 ◯ Example a-5 Batch 124.1 β PGMEA BYK-2164 100 249.6 α2.01 1.36 Δ Example a-6 Batch 124.1 β MeOH — — 1012.3 α 8.16 4.16 X C.Example a-7 Batch 124.1 β PGME — — 1006.6 α 8.11 2.13 X C. Example a-8Batch 124.1 β Toluene — — 1111.1 β 8.95 1.02 X C. Example a-9 Batch124.1 β MEK — — 1213.4 α 9.78 1.39 X C. Example  a-10 Batch 124.1 β MeOHBYK-2000 100 146.30 α 1.18 2.13 ◯ Example  a-11 Batch 124.1 β TolueneBYK-2000 100 159.4 β 1.28 2.39 ◯ Example b-1 Batch 136.9 α IPA — —1634.6 β 11.94 2.36 X C. Example b-2 Batch 136.9 α IPA BYK-2000 100412.3 β 3.01 3.49 ◯ Example b-3 Batch 136.9 α IPA BYK-2164 100 463.1 β3.38 1.69 ◯ Example

(Case of Using the Microreactor)

In Examples B, the A solution corresponds to the first fluid to beprocessed which is introduced from the first introduction part d1 of themicroreactor shown in FIG. 2(A), and the B solution corresponds to thesecond fluid to be processed which is introduced from the secondintroduction part d2 of the same. Both the solutions are interchangeablewith each other. Meanwhile, in Examples B, ULREA (manufactured by M.Technique Co., Ltd.) was used as the microreactor.

The solutions A and B were mixed in the microreactor with the operation,the condition of which are shown in Table 4 below; and similarly toExamples A, pigment microparticles were produced according to the step 0to the step 2 shown in FIG. 1 .

(Step 0)

Preparation of the separating solvent for the pigment microparticle (Asolution) and the raw material solution of the pigment microparticlesolution (B solution) described in Table 5: both the A and B solutionswere prepared by using the above-mentioned Clearmix CLM-2.2S for 30minutes with the liquid temperature of 40° C., while the rotationnumbers thereof were 10000 rpm for the A solution and 20000 rpm for theB solution.

(Step 1)

The dissolved solution of the organic pigment (B solution) was mixedwith the poor solvent (A solution) by using the microreactor shown inFIG. 1 to separate the organic pigment microparticles. The slurrycontaining the organic pigment microparticles obtained in the step 1 wasfiltrated; and the microparticles thus recovered were washed with purewater (step c) to obtain a wet cake of the organic pigmentmicroparticles, or the dried powder of the organic pigmentmicroparticles by conducting the drying treatment thereof with avacuum-drying or the like.

(Step 2)

The wet cake of the organic pigment microparticles or the dry powderthereof was introduced into the solvent having a partial dissolvabilityto the organic pigment microparticle and having a surfactant or adispersant added therein (particle property control solution); and then,the resulting mixture was subjected to the stirring treatment for aprescribed time by using the above-mentioned Clearmix CLM-2.2S.

TABLE 4 Disk rotation A solution supply condition B solution supplycondition Discharged solution Experiment number Flow rate TemperatureFlow rate Temperature Measuredtemperature No. (rpm) (mL/min) (° C.)(mL/min) (° C.) pH (° C.) 1-1 to 1-11 1700 500 5.1 50 40.1 2.45 26.4 2-1to 2-3  1700 800 5.2 30 40.2 2.08 21.4

TABLE 5 Experiment No. A solution B solution 1-1 to 1-11 20 wt % aceticDMSO/40 wt % BTMA MeOH soln/PR254 acid/pure water 63/28/9 (weight ratio)2-1 to 2-3 20 wt % acetic DMSO/40 wt % BTMA MeOH sol/PR122 acid/purewater 63/28/9 (weight ratio)

Next, similarly to the batch method, the pigment microparticles obtainedin the steps 1 and 2 were compared with each other by calculating theaverage primary particle diameters with the TEM observation andmeasuring the degrees of crystallinity with the XRD measurement of them(see, Table 6 below). Meanings of the symbols and abbreviations are assame as those of the batch method. Also, definitions of the symbols ⊚,◯, Δ, are the same as those of the batch method.

TABLE 6 Step 2 Stirring Stepc washing Ratio of Average surfactant/Average Step c→ 2 Step c→ 2 primary dispersant primary Change in Changein Example/ Exper- Separa- particle to pigment particle particle degreeof Compar- iment tion diameter Crystal Surfactant/ (% by diameterCrystal diameter crystallinity Judge- ative No. method (nm) type Solventdispersant weight) (nm) type [Da/Db] [Xa/Xb] ment Example 1-1 ULREA 11.1β PGMEA — — 101.1 α 9.11 1.46 X C. Example 1-2 ULREA 11.1 β PGMEABYK-2000 100 16.4 α 1.48 2.31 ⊚ Example 1-3 ULREA 11.1 β PGMEA BYK-108100 26.3 α 2.37 2.16 ⊚ Example 1-4 ULREA 11.1 β PGMEA Pelex TR 100 24.9α 2.24 3.16 ⊚ Example 1-5 ULREA 11.1 β MeOH — — 41.1 α 3.70 4.16 Δ C.Example 1-6 ULREA 11.1 β Acetone — — 24.1 α 2.17 3.16 Δ C. Example 1-7ULREA 11.1 β PGME — — 18.1 α 1.63 2.13 Δ C. Example 1-8 ULREA 11.1 βToluene — — 134.6 β 12.13 1.02 X C. Example 1-9 ULREA 11.1 β MEK — —19.6 α 1.77 1.39 Δ C. Example  1-10 ULREA 11.1 β MeOH BYK-2000 100 12.1α 1.09 2.13 ⊚ Example  1-11 ULREA 11.1 β Toluene BYK-2000 100 16.9 β1.52 1.97 ⊚ Example 2-1 ULREA 13.4 α IPA — — 34.1 β 2.54 2.36 X C.Example 2-2 ULREA 13.4 α IPA BYK-2000 100 15.6 β 1.16 3.49 ⊚ Example 2-3ULREA 13.4 α IPA BYK-2164 100 29.6 β 2.21 1.69 ⊚ Example

From the TEM picture of the red pigment nanoparticles of the presentinvention obtained in Experiment No. 1-2 of Examples B (FIG. 30 ), itbecame clear that when the production method of the present invention isapplied to Examples B, owing to the action of the particle propertycontrol solution, the necking and growth in the obtained red organicpigment microparticles can be suppressed.

Meanwhile, Experiment No. 2-1 is regarded as Comparative Example,because at the time of the above-mentioned TEM observation, two or moreof the particle having the size of more than 8.0 times relative to dbwere confirmed among the individual pigment microparticles in the step 2(after the action).

Group of Examples C

Next, the group of Examples C (blue organic pigment) will be explained.

For the XRD measurement of Examples C, the powder X-ray diffractionmeasurement apparatus (product name: X'Pert PRO MPD, manufactured byPANalytical B. V.) was used. The measurement conditions were as follows:measurement range of 6 to 60°, Cu anticathode, tube voltage of 45 kV,tube current of 40 mA, and scanning speed of 16°/min.

For the TEM observation, the transmission electron microscope JEM-2100(manufactured by JEOL Ltd.) was used. The observation conditions withthe acceleration voltage of 80 kV and the observation magnification of25000 were employed.

(Case of Using the Microreactor)

The A solution and the B solution were mixed with the condition shownbelow, and by following the procedure shown below, the blue organicpigment microparticles were produced.

Meanwhile, in Examples C. ULREA (manufactured by M. Technique Co., Ltd.)was used as the microreactor. In this case, the A solution correspondsto the first fluid to be processed which is introduced from the firstintroduction part d1 of the microreactor shown in FIG. 2(A), and the Bsolution corresponds to the second fluid to be processed which isintroduced from the second introduction part d2 of the same. The firstintroduction part d1 and the second introduction part d2 areinterchangeable with each other.

The experimental prescriptions of Examples C are shown in Table 7.

TABLE 7 A solution B solution Experiment Measured Measured No.Prescription pH temperature (° C.) Prescription pH temperature (° C.) 1Pure water 6.9 13.9 CuPc/TiOPc/CoPc/H₂SO₄ = <1 — 2.1/0.6/0.3/97 (weightratio) 2 Pure water 6.9 13.9 CuPc/TiOPc/CoPc/H₂SO₄ = <1 —2.1/0.45/0.45/97 (weight ratio) 3 Pure water 6.9 13.9 CuPc/H₂SO₄ = <1 —3/97 ( weight ratio)

Meanwhile, the abbreviations used in the above are as follows; CuPc:copper phthalocyanine. TiOPc: titanyl phthalocyanine, CoPc: cobaltphthalocyanine, and H₂S₄O: concentrated sulfuric acid.

In Examples C, too, similarly to Examples A, the pigment microparticleswere produced according to the steps 0 to 2 shown in FIG. 1 .

(Step 0)

For mixing and separation with the experimental prescriptions describedabove by using ULREA, the A solution and the B solution were prepared inthe way as described below.

Preparation Condition of the Separating Solvent of the Organic PigmentParticles (A Solution)

As described in the experimental prescriptions above, in the case of asingle solvent, preparation thereof is not necessary, however, forexample, in the case that the experimental prescription described inPatent Document 8 is used, it is preferable to stir by using Clearmix.For example, in Examples C, stirring is conducted by using CLM-2.2S withthe rotation number of 10000 rpm for the period of 30 minutes.

Preparation Condition of the Raw Material Solution of the OrganicPigment Particles (B Solution)

Stirring was conducted by using Clearmix CLM-2.2S with the rotationnumber of 20000 rpm for the period of 30 minutes. The preparationtemperatures of both the A solution and the B solution were made 40° C.

(Step 1)

With the operation conditions described in Table 8 shown below, by usingULREA, the separating solvent of the organic pigment particles (Asolution) and the raw material solution of the organic pigment particles(B solution) were mixed to separate the blue organic pigmentmicroparticles.

The slurry containing the blue organic pigment microparticles obtainedin the step 1 was filtrated; and the blue organic pigment microparticlesthus recovered were washed with pure water (step c) to obtain a wet cakeof the blue organic pigment microparticles (or the dried powder of theblue organic pigment microparticles obtained by conducting the dryingtreatment thereof with a vacuum-drying or the like).

(Step 2)

The wet cake of the blue organic pigment microparticles (or the drypowder thereof) obtained in the step 1 was introduced into the solventwhich has a partial dissolvability to the organic pigment microparticlesolely, or into the said solvent added with a surfactant and/or adispersant (particle property control solvent); and then, the resultingmixture was subjected to the stirring treatment for a prescribed time byusing Clearmix.

TABLE 8 Disk rotation Supply condition of A solution Supply condition ofB solution Discharged solution Experiment number Flow rate TemperatureFlow rate Temperature Measured No. (rpm) (mL/min) (° C.) (mL/min) (° C.)pH temperature(° C.) 1 1700 600 10.1 30 40.6 <1 23.1 2 1700 600 10.2 3040.1 <1 22.9 3 1700 600 10.4 30 41.2 <1 22.9

The changes in the particle diameter and degree of crystallinity of theblue organic pigment microparticles before and after the stirringtreatment in the case of using the microreactor are shown in Table 9below.

TABLE 9 Particle properties after step c (washing) Average Step 2(action) primary Ratio of particle surfactant/ diameter: dispersantExperiment Separation Db Crystal Surfactant/ to pigment No. Pigmentapparatus (nm) type Solvent dispersant (wt %) 1-1 Plural ULREA 9.8 αStyrene — 1-2 Plural ULREA 9.8 α Toluene — 1-3 Plural ULREA 9.8 α Xylene— 1-4 Plural ULREA 9.8 α THF — 1-5 Plural ULREA 9.8 α IPA — 1-6 PluralULREA 9.8 α Styrene Pelex TR 100 1-7 Plural ULREA 9.8 α Styrene BYK-2164100 1-8 Plural ULREA 9.8 α Styrene BYK-2000 100 1-9 Plural ULREA 9.8 αStyrene BYK-108 100  1-10 Plural ULREA 9.8 α THF BYK-2164 100  1-11Plural ULREA 9.8 α IPA BYK-2001 100 2-1 Plural ULREA 8.6 α Styrene — 2-2Plural ULREA 8.6 α Toluene — 2-3 Plural ULREA 8.6 α Xylene — 2-4 PluralULREA 8.6 α THF — 2-5 Plural ULREA 8.6 α IPA — 2-6 Plural ULREA 8.6 αStyrene Pelex TR 100 2-7 Plural ULREA 8.6 α Styrene BYK-2164 100 2-8Plural ULREA 8.6 α Styrene BYK-2000 100 2-9 Plural ULREA 8.6 α StyreneBYK-108 100  2-10 Plural ULREA 8.6 α THF BYK-2164 100  2-11 Plural ULREA8.6 α IPA BYK-2001 100 3-1 Single ULREA 8.7 α 1 wt % aq. — H₂SO₄ 3-2Single ULREA 8.7 α 0.1 wt % aq. — H₂SO₄ 3-3 Single ULREA 8.7 α 0.01 wt %aq. — H₂SO₄ 3-4 Single ULREA 8.7 α 1 wt % aq SDBS 100 H₂SO₄ 3-5 SingleULREA 8.7 α 0.1 wt % aq. SDBS 100 H₂SO₄ Particle properties after step 2(action) Average Change of Change primary particle ofdegree of particlediameter before crystallinity diameter: and after before and Example/Experiment Da Crystal the action after the action Comparative No. (nm)type (Da/Db) (Xa/Xb) Judgement Example 1-1 54.9 α 5.60 2.31 XComparative Example 1-2 61.9 α 6.32 1.65 X Comparative Example 1-3 46.9α 4.79 1.39 X Comparative Examole 1-4 40.9 α 4.17 1.36 X ComparativeExample 1-5 41.2 α 4.20 1.01 X Comparative Example 1-6 19.3 α 1.97 1.19⊚ Example 1-7 11.2 α 1.14 2.31 ⊚ Example 1-8 33.1 α 3.38 2.64 ⊚ Example1-9 24.1 α 2.46 2.39 ⊚ Example  1-10 21.4 α 2.18 2.46 Δ Example  1-1118.9 α 1.93 1.49 ⊚ Example 2-1 49.8 α 5.79 3.12 X Comparative Example2-2 46.9 α 5.45 3.23 X Comparative Examole 2-3 47.8 α 5.56 2.16 XComparative Example 2-4 49.6 α 5.77 1.69 X Comparative Example 2-5 43.9α 5.10 1.03 X Comparative Example 2-6 14.5 α 1.69 1.46 ⊚ Example 2-716.3 α 1.90 1.65 ⊚ Example 2-8 13.2 α 1.53 1.89 Δ Example 2-9 10.1 α1.17 1.34 ⊚ Example  2-10 10.9 α 1.27 1.39 ⊚ Example  2-11 16.3 α 1.901.41 ⊚ Example 3-1 74.9 α 8.61 1.06 X Comparative Example 3-2 79.6 α9.15 1.09 X Comparative Example 3-3 73.6 α 8.46 1.64 X ComparativeExample 3-4 32.1 α 3.69 2.31 Δ Example 3-5 33.1 α 3.80 2.46 ⊚ Example

Meanwhile, the abbreviations and definitions of the terms in Examples Cabove are summarized in Table 10 below.

TABLE 10 Abbreviation/Term Definition THF Tetrahydrofuran IPA Isopropylalcohol H₂SO₄ Sulfuric acid CuPc Copper phthalocyanine (blue organicpigment) TiOPc Titanyl phthalocyanine (blue organic pigment) CoPc Cobaltphthalocyanine (blue organic pigment) SDBS Sodium dodecylbenzenesulfonate Measurement method of Average particle diameter of 100particles observed in plural average primary view fields at the time ofTEM observation with 25000 particle diameter magnifications. Degree ofcrystallinity The ratio of the crystalized component relative to thetotal of the crystalized and amorphous components obtained by the XRDmeasurement. Durability to light, heat, humidity, or the like is higherwhen the pigment’s degree of crystallinity is higher.

Meanwhile, definitions of the evaluation in Table 9 are the same asthose of Examples B relating to the red organic pigments.

The average primary particle diameter of the blue organic pigmentmicroparticles after the step c (washing) and after the step 2 (action)each was calculated by way of the TEM observation, and the degree ofcrystallinity of the same was measured by way of the XRD measurement,and they were compared (Table 9). In addition, the TEM pictures obtainedin Experiment No. 1 to 7 of Examples C are shown (FIG. 32 to FIG. 35 ).The TEM picture of Comparative Example obtained in Experiment No. 3-1 ofExamples C is also shown (FIG. 37 ).

According to the experimental results above, in Comparative Exampleswherein the solvent which has a partial dissolvability to the blueorganic pigment microparticles (in Table 9, this solvent is simply shownas “Solvent”), containing neither a surfactant nor a dispersant, wasused in the step 2, the necking and growth were resulted. FIG. 37 showsone example thereof. On the other hand, when the production method ofthe present invention was applied to Examples C, it became clear thatthe necking and growth could be suppressed in the obtained blue organicpigment microparticles.

(Case of the Batch Method)

Similarly to the case of using the microreactor, the blue organicpigment microparticles were produced by mixing the A solution and the Bsolution prepared in accordance with the prescriptions shown in Table 11below.

TABLE 11 A solution B solution Experiment Measured Measured No.Prescription pH temperature (° C.) Prescription pH temperature (° C.) 4Pure water 6.9 13.9 CuPc/TiOPc/CoPc/H₂SO₄ = <1 — 2.1/0.6/0.3/97 (weightratio) 5 Pure water 6.9 13.9 CuPc/TiOPc/CoPc/H₂SO₄ = <1 —2.1/0.45/0.45/97 (weight ratio) 6 Pure water 6.9 13.9 CuPc/H₂SO₄ = <1 —3/97 (weight ratio)

Meanwhile, the abbreviations used in the above are as follows; CuPc:copper phthalocyanine. TiOPc: titanyl phthalocyanine, CoPc: cobaltphthalocyanine, and H₂S₄O: concentrated sulfuric acid.

The contents of the treatments in Examples C are as follows.

(Step 0)

For mixing and separation with the experimental prescriptions describedabove by using the batch method, the A solution and the B solution wereprepared in the way as described below.

Preparation Condition of the Separating Solvent of the Organic PigmentParticle (A Solution)

As described in the experimental prescriptions above, in the case of asingle solvent, preparation thereof is not necessary; however, forexample, in the case that the experimental prescription described inPatent Document 8 is used, it is preferable to stir by using Clearmix.For example, in Examples C, stirring is conducted by using CLM-2.2S withthe rotation number of 10000 rpm for the period of 30 minutes.

Preparation Condition of the Raw Material Solution of the OrganicPigment Particle (B Solution)

Stirring was conducted by using Clearmix CLM-2.2S with the rotationnumber of 20000 rpm for the period of 30 minutes.

The preparation temperatures of both the A solution and the B solutionwere made 40° C.

(Step 1)

The raw material solution of the organic pigment particle (B solution)was introduced into the separating solvent of the organic pigmentparticle (A solution) in a beaker with stirring the A solution by meansof a magnetic stirrer and a stirring bar at the rotation number of 300rpm so as to effect the mixing of the A solution with the B solution toseparate the blue organic pigment microparticles. After the slurrycontaining the blue organic pigment microparticles obtained in the step1 were filtrated, the blue organic pigment microparticles were washedwith pure water (step c) to obtain a wet cake of the blue organicpigment microparticles (or the dried powder of the blue organic pigmentmicroparticles obtained by conducting the drying treatment thereof witha vacuum-drying or the like).

(Step 2)

The wet cake of the blue organic pigment microparticles (or the drypowder thereof) obtained in the step 1 was introduced into the solventhaving a partial dissolvability to the organic pigment microparticlesolely and having a surfactant and/or a dispersant added therein(particle property control solvent); and then, the resulting mixture wassubjected to the stirring treatment for a prescribed time by usingClearmix.

The changes in the particle diameter and degree of crystallinity of theblue organic pigment microparticles before and after the stirringtreatment with the batch method are shown in Table 12 below.

TABLE 12 Particle properties after step c (washing) Average Step 2(action) primary Ratio of particle surfactant/ diameter: dispersantExperiment Separation Db Crystal Surfactant/ to pigment No. Pigmentapparatus (nm) type Solvent dispersant (wt %) 4-1 Plural Batch 79.8 αStyrene — 4-2 Plural Batch 79.8 α Toluene — 4-3 Plural Batch 79.8 αXylene — 4-4 Plural Batch 79.8 α THF — 4-5 Plural Batch 79.8 α IPA — 4-6Plural Batch 79.8 α Styrene Pelex TR 100 4-7 Plural Batch 79.8 α StyreneBYK-2164 100 4-8 Plural Batch 79.8 α Styrene BYK-2000 100 4-9 PluralBatch 79.8 α Styrene BYK-108 100  4-10 Plural Batch 79.8 α THF BYK-2164100  4-11 Plural Batch 79.8 α IPA BYK-2001 100 5-1 Plural Batch 69.7 αStyrene — 5-2 Plural Batch 69.7 α Toluene — 5-3 Plural Batch 69.7 αXylene — 5-4 Plural Batch 69.7 α THF — 5-5 Plural Batch 69.7 α IPA — 5-6Plural Batch 69.7 α Styrene Pelex TR 100 5-7 Plural Batch 69.7 α StyreneBYK-2164 100 5-8 Plural Batch 69.7 α Styrene BYK-2000 100 5-9 PluralBatch 69.7 α Styrene BYK-108 100  5-10 Plural Batch 69.7 α THF BYK-2164100  5-11 Plural Batch 69.7 α IPA BYK-2001 100 6-1 Single Batch 71.4 α 1wt % aq. — H₂SO₄ 6-2 Single Batch 71.4 α 0.1 wt % aq. — H₂SO₄ 6-3 SingleBatch 71.4 α 0.01 wt % aq. — H₂SO₄ 6-4 Single Batch 71.4 α 1 wt % aq.SDBS 100 H₂SO₄ Particle properties after step 2 (action) Average Changeof Change primary particle ofdegree of particle diameter beforecrystallinity diameter: and after before and Example/ Experiment DaCrystal the action after the action Comparative No. (nm) type (Da/Db)(Xa/Xb) Judgement Example 4-1 512.3 α 6.42 1.69 X Comparative Example4-2 498.6 α 6.25 1.69 X Comparative Example 4-3 401.2 α 5.03 2.31 XComparative Example 4-4 394.6 α 4.94 2.65 X Comparative Example 4-5379.8 α 4.76 1.97 X Comparative Example 4-6 169.4 α 2.12 1.67 ◯ Example4-7 174.6 α 2.19 1.99 ◯ Example 4-8 169.4 α 2.12 1.67 ◯ Example 4-9131.6 α 1.65 2.31 ◯ Example  4-10 246.5 α 3.09 2.36 Δ Example  4-11316.2 α 3.96 1.69 ◯ Example 5-1 600.3 α 8.61 1.97 X Comparative Example5-2 498.4 α 7.15 2.39 X Comparative Example 5-3 394.6 α 5.66 1.64 XComparative Example 5-4 466.3 α 6.69 1.69 X Comparative Example 5-5399.9 α 5.74 1.65 X Comparative Example 5-6 136.4 α 1.96 1.57 ◯ Example5-7 269.4 α 3.87 1.89 ◯ Example 5-8 213.4 α 3.06 2.34 ◯ Example 5-9276.4 α 3.97 2.69 Δ Example  5-10 226.4 α 3.25 3.64 ◯ Example  5-11276.1 α 3.96 1.41 ◯ Example 6-1 697.8 α 9.77 2.16 X Comparative Example6-2 794.5 α 11.13 2.54 X Comparative Example 6-3 599.4 α 8.39 2.46 XComparative Example 6-4 241.6 α 3.38 2.36 ◯ Example

The blue organic pigment microparticles obtained after the step 0(washing) and the step 2 (action) were compared with each other bycalculating the average primary particle diameters by way of the TEMobservation and measuring the degrees of crystallinity by way of the XRDmeasurement of them (Table 12). Meanings of the symbols, abbreviations,etc. are the same as those of the case of using the microreactor.

According to the experimental results above, similarly to Examples C inwhich the microreactor was used, in the batch method, too, when thesolvent which has a partial dissolvability to the blue organic pigmentmicroparticles (in Table 12, this solvent is simply shown as “Solvent”)containing neither a surfactant nor a dispersant was used in the step 2,the necking and growth were resulted. FIG. 36 shows the picture of theTEM observation of the copper-titanyl-cobalt phthalocyaninemicroparticles obtained in Experiment No. 4-4 as one example thereof. Onthe other hand, when the production method of the present invention wasapplied to Examples C, it became clear that owing to the action of theparticle property control solution, the necking and growth could besuppressed in the obtained blue organic pigment microparticles.

As discussed above, from Examples A, Examples B, and Examples C, it isdemonstrated that the present invention is effective to organic materialmicroparticles in general.

EXPLANATION OF NUMERAL SYMBOLS

-   1 First processing surface-   2 Second processing surface-   10 First processing member-   11 First holder-   20 Second processing member-   21 Second holder-   d1 First introduction part-   d2 Second introduction part-   d10 Opening-   d20 Opening

1. A method for modifying an organic material microparticle, wherein the method is to modify an organic material microparticle without substantially changing a particle diameter of the organic material microparticle; the method comprises a step in which a particle property control solution having a surfactant dissolved in a solvent which has a partial dissolvability to the organic material microparticle is made to act to the organic material microparticle; and by conducting this step, a degree of crystallinity of the organic material microparticle is enhanced so as to modify the organic material microparticle such that the degree of crystallinity thereof may be matched with a prescribed intended condition.
 2. A method for modifying an organic material microparticle, wherein the method is to modify an organic material microparticle without substantially changing a particle diameter of the organic material microparticle; the method comprises a step in which a particle property control solution having a surfactant dissolved in a solvent which has a partial dissolvability to the organic material microparticle is made to act to the organic material microparticle; by conducting this step, a crystal type of the organic material microparticle is changed so as to modify the organic material microparticle in such a way that the crystal type thereof may be matched with a prescribed intended condition.
 3. The method for modifying the organic material microparticle according to claim 1, wherein a rate of change in the particle diameter of the organic material microparticle measured before and after the treatment in the step (after treatment in the step (A)/before treatment in the step (B)) is in a range of 1 to
 4. 4. The method for modifying the organic material microparticle according to claim 1, wherein the organic material microparticle before the treatment in the step contains an amorphous portion at least in part thereof. 